Massimo Volpe

Q: What Schools Are Affiliated With Massimo Volpe

Massimo Volpe is affiliated with the following schools: Cornell University, University of Medicine and Dentistry of New Jersey, Sapienza University of Rome, Università Cattolica del Sacro Cuore, University of Zurich, University of Pennsylvania, Harvard University, University of Oslo, University of Milan, University of Konstanz

Massimo Volpe's AcademicInfluence.com Rankings

Massimo Volpe

Philosophy

#4599

World Rank

#7179

Historical Rank

Logic

#2016

World Rank

#2910

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Massimo Volpe's Degrees

Doctorate Medicine University of Milan

Why Is Massimo Volpe Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Massimo Volpe's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (2006) (1767)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era (2020) (673)
High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells: Role of Protein Kinase C and Reactive Oxygen Species (2003) (456)
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. (2015) (388)
Acute anti-ischemic effect of testosterone in men with coronary artery disease. (1999) (368)
Mammalian target of rapamycin signaling in cardiac physiology and disease. (2014) (330)
Age and Multimorbidity Predict Death Among COVID-19 Patients (2020) (294)
[The progression from hypertension to congestive heart failure]. (2011) (286)
Deletion of p66shc Gene Protects Against Age-Related Endothelial Dysfunction (2003) (284)
Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease (1996) (255)
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. (2013) (252)
Insulin-Like Growth Factor-1 as a Vascular Protective Factor (2004) (249)
Rheb is a Critical Regulator of Autophagy During Myocardial Ischemia: Pathophysiological Implications in Obesity and Metabolic Syndrome (2012) (245)
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. (1992) (235)
Natriuretic peptides in cardiovascular diseases: current use and perspectives. (2014) (220)
Gene Silencing of the Mitochondrial Adaptor p66Shc Suppresses Vascular Hyperglycemic Memory in Diabetes (2012) (212)
Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress (2007) (210)
Current Situation of Medication Adherence in Hypertension (2017) (204)
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment (2015) (197)
Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. (2008) (189)
Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. (2008) (178)
Reactive Oxygen Species Mediate Endothelium-Dependent Relaxations in Tetrahydrobiopterin-Deficient Mice (2001) (175)
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. (2015) (175)
Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual (2007) (170)
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage (2014) (167)
MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery (2013) (158)
Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. (2007) (157)
Trehalose-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction. (2018) (156)
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. (2017) (154)
Long-term persistence with antihypertensive drugs in new patients (2002) (153)
Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. (1994) (153)
Activation of NADPH Oxidase 4 in the Endoplasmic Reticulum Promotes Cardiomyocyte Autophagy and Survival During Energy Stress Through the Protein Kinase RNA-Activated-Like Endoplasmic Reticulum Kinase/Eukaryotic Initiation Factor 2&agr;/Activating Transcription Factor 4 Pathway (2013) (147)
Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. (2006) (144)
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia (2007) (136)
Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats. (1990) (134)
Blood pressure control in Italy: results of recent surveys on hypertension (2007) (133)
Differential Roles of GSK-3&bgr; During Myocardial Ischemia and Ischemia/Reperfusion (2011) (133)
Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study (2012) (131)
Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. (2011) (130)
Arterial stiffness is an independent risk factor for cognitive impairment in the elderly: a pilot study (2005) (129)
Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients (2007) (129)
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I. (2016) (128)
Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels (2017) (120)
Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension (2011) (120)
Salt‐Regulating Hormones in Young Normotensive Obese Subjects: Effects of Saline Load (1994) (120)
Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. (2009) (119)
Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus (2015) (119)
Development of heart failure in recent hypertension trials (2008) (118)
Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. (1990) (118)
Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in Humans (2004) (115)
Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. (1986) (114)
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years (2019) (112)
Effect of Atrial Natriuretic Factor on Blood Pressure, Renin, and Aldosterone in Goldblatt Hypertension (1985) (111)
Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? (2003) (109)
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. (2005) (108)
Selective Inhibition of Protein Kinase Cβ2 Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells (2004) (108)
Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study (2007) (104)
Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers (2012) (102)
Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension (2009) (101)
The gene encoding atrial natriuretic peptide and the risk of human stroke. (1999) (101)
Natriuretic peptides and cardio-renal disease. (2014) (101)
Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. (1999) (101)
mTORC2 regulates cardiac response to stress by inhibiting MST1. (2015) (100)
New Insights into the Role of Mitochondrial Dynamics and Autophagy during Oxidative Stress and Aging in the Heart (2014) (99)
Abnormalities of Sodium Handling and of Cardiovascular Adaptations During High Salt Diet in Patients With Mild Heart Failure (1993) (99)
Population-level changes to promote cardiovascular health (2012) (99)
Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study (2005) (98)
Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. (1991) (98)
Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome. (2007) (97)
The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. (2002) (96)
Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats. (1996) (95)
Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. (1986) (95)
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin (2007) (94)
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress (2014) (93)
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future (2017) (93)
Deletion of the Activated Protein-1 Transcription Factor JunD Induces Oxidative Stress and Accelerates Age-Related Endothelial Dysfunction (2013) (91)
A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients (2010) (88)
Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection (2005) (86)
Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension (2012) (86)
Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure (2005) (84)
Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. (2012) (83)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text (2007) (82)
Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials. (2011) (80)
Angiotensin II Directly Stimulates Release of Atrial Natriuretic Factor in Isolated Rabbit Hearts (1993) (78)
Transcatheter Closure of Post-myocardial Infarction Ventricular Septal Rupture (2013) (77)
Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes. (2015) (75)
Vagal Mediation of the Effects of Atrial Natriuretic Factor on Blood Pressure and Arterial Baroreflexes in the Rabbit (1987) (75)
Enhanced TNFα and oxidative stress in patients with heart failure: effect of TNFα on platelet O2 - production (2003) (74)
Right Ventricular Dysfunction in Patients with End-Stage Renal Disease (2010) (74)
Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty. (1999) (71)
Non-pharmacological control of plasma cholesterol levels. (2008) (71)
NPR-C: a component of the natriuretic peptide family with implications in human diseases (2010) (71)
[Population-level changes to promote cardiovascular health]. (2013) (71)
Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress? (2013) (70)
Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH (2008) (70)
Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy. (2001) (69)
SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory (2013) (69)
The atrial natriuretic peptide: a changing view. (2001) (69)
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project (2020) (69)
The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. (2013) (68)
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides (2011) (68)
The challenge of polypharmacy in cardiovascular medicine (2010) (68)
SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together. (2013) (67)
Beyond hypertension toward guidelines for cardiovascular risk reduction. (2004) (67)
Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. (1998) (67)
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. (2013) (66)
Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy. (1988) (66)
Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective. (2013) (66)
Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat. (1999) (66)
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study (2007) (66)
The PlA1/A2 polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients (2007) (65)
Left bundle‐branch block—pathophysiology, prognosis, and clinical management (2007) (65)
Polypharmacy in Heart Failure Patients (2014) (64)
Genetic polymorphism of the renin–angiotensin–aldosterone system and arterial hypertension in the Italian population: the GENIPER Project (2003) (64)
Endothelial Dysfunction and Stroke (2001) (63)
Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system. (1986) (63)
IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. (2011) (62)
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. (1993) (62)
Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension. (1986) (62)
Angiotensin II receptor blockers and myocardial infarction: deeds and misdeeds (2005) (61)
An update on hypertensive emergencies and urgencies (2015) (61)
Pharmacological Modulation of Autophagy During Cardiac Stress (2012) (60)
Gene polymorphisms of the renin–angiotensin–aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant (2004) (60)
Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. (2009) (60)
Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells. (1999) (60)
Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic β1-selective receptor blockade (2002) (59)
Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases (2017) (58)
Why in 2016 are patients with hypertension not 100% controlled? A call to action. (2016) (57)
VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes (2018) (56)
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. (2007) (55)
Can primary care professionals' adherence to Evidence Based Medicine tools improve quality of care in type 2 diabetes mellitus? A systematic review. (2009) (55)
Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy (2009) (55)
Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database (2017) (55)
Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. (1997) (55)
Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease. (2005) (55)
Microalbuminuria screening in patients with hypertension: recommendations for clinical practice (2007) (54)
A role of TNF‐α gene variant on juvenile ischemic stroke: a case–control study (2005) (54)
Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy (2019) (54)
Is it time to measure microalbuminuria in hypertension? (2003) (54)
Role of the angiotensin II AT2‐subtype receptors in the blood pressure‐lowering effect of losartan in salt‐restricted rats (1998) (54)
p66Shc protein, oxidative stress, and cardiovascular complications of diabetes: the missing link (2009) (53)
[Recommendations for the clinical use of cardiac natriuretic peptides]. (2005) (53)
Personalized medicine—a modern approach for the diagnosis and management of hypertension (2017) (52)
Angiotensin-II receptor blockers: benefits beyond blood pressure reduction? (2005) (52)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies (2020) (52)
Clinical and neuropsychological correlates of cerebral ventricular enlargement in schizophrenia. (1985) (51)
Etiology and pathophysiology of stroke as a complex trait. (2000) (51)
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study (2010) (51)
Inhibition of Protein Kinase C&bgr; Prevents Foam Cell Formation by Reducing Scavenger Receptor A Expression in Human Macrophages (2008) (51)
Is early and fast blood pressure control important in hypertension management? (2017) (49)
Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human Disease (2016) (49)
Differential Modulation of Uncoupling Protein 2 in Kidneys of Stroke-Prone Spontaneously Hypertensive Rats Under High-Salt/Low-Potassium Diet (2013) (49)
Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension (2020) (48)
Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans. (1994) (48)
Evaluation of microvascular structure in humans: a ‘state-of-the-art’ document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension (2014) (47)
Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy (2016) (46)
NOX4 regulates autophagy during energy deprivation (2014) (46)
Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys (2015) (45)
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents. (2007) (45)
Eligibility for the Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy (2015) (45)
2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy (2013) (44)
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. (2014) (44)
Hypertension guidelines: criteria that might make them more clinically useful. (2002) (44)
Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. (2005) (43)
Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension. (1983) (43)
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension (2021) (43)
Effects of atorvastatin and rosuvastatin on renal function: a meta-analysis. (2012) (43)
Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy (2016) (43)
Angiotensin Converting Enzyme Inhibition Restores Cardiac and Hormonal Responses to Volume Overload in Patients With Dilated Cardiomyopathy and Mild Heart Failure (1992) (42)
Pharmacological restoration of autophagy reduces hypertension-related stroke occurrence. (2019) (42)
Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development (2019) (42)
Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study (2010) (42)
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension (2020) (42)
Hemodynamic and hormonal effects of atrial natriuretic factor in patients with essential hypertension. (1987) (42)
Alzheimer’s disease and endothelial dysfunction (2010) (42)
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study (2019) (42)
Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. (2009) (42)
Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin (2012) (42)
Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? (2013) (42)
Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc. (2018) (42)
Revisiting the Relationship Between Blood Pressure and Insulin-Like Growth Factor-1 (2014) (42)
Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension. (1984) (41)
2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept (2009) (41)
Hypertension in Young People: Epidemiology, Diagnostic Assessment and Therapeutic Approach (2015) (41)
Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms (2020) (41)
Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report (2014) (41)
Converting enzyme inhibition prevents the effects of atrial natriuretic factor on baroreflex responses in humans. (1990) (41)
Angiotensin type 2 receptor in hypertensive cardiovascular disease (2011) (40)
Contribution of Genetic Factors to Renal Lesions in the Stroke-Prone Spontaneously Hypertensive Rat (2003) (40)
Abnormalities of endothelial function in the pathogenesis of stroke: the importance of endothelin. (2000) (40)
Diltiazem in the Treatment of Mild or Moderate Essential Hypertension. Comparison with Metoprolol in a Crossover Double‐Blind Trial (1984) (40)
QT/QS2 ratio as an index of autonomic tone changes. (1984) (39)
Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy (2010) (39)
Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system. (2012) (39)
p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor. (2003) (39)
Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing (2012) (39)
Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients (2020) (39)
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease. (2012) (39)
Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancer. (2011) (38)
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts (2002) (38)
Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity (2019) (38)
QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly. (2013) (38)
Early-onset ischaemic stroke: Analysis of 58 polymorphisms in 17 genes involved in methionine metabolism (2010) (37)
Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials (2009) (37)
Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination. (2012) (37)
Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study (2012) (37)
Arterial hypertension in cancer: The elephant in the room. (2019) (37)
Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass (2007) (36)
Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril. (1992) (36)
Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy. (2020) (36)
Restoring the dysfunctional endothelium. (2007) (36)
Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications (2022) (35)
Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population (2005) (35)
Prevalence and clinical outcomes of white‐coat and masked hypertension: Analysis of a large ambulatory blood pressure database (2018) (35)
Hypertension, stroke, and endothelium (2005) (35)
In vivo left ventricular anatomy in rats with two‐kidney, one clip and one‐kidney, one clip renovascular hypertension (1992) (34)
Cardiac autonomic responses to volume overload in normal subjects and in patients with dilated cardiomyopathy. (1999) (34)
Decreased nocturnal systolic blood pressure fall in older subjects with depression (2009) (34)
Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor. (1989) (34)
Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy. (2019) (34)
Erythropoietin and the heart: facts and perspectives. (2011) (34)
C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling (2013) (34)
Heart Failure Progression in Hypertrophic Cardiomyopathy　- Possible Insights From Cardiopulmonary Exercise Testing. (2016) (34)
Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors. (1997) (33)
Pulsatile Stretch Induces Release of Angiotensin II and Oxidative Stress in Human Endothelial Cells: Effects of ACE Inhibition and AT1 Receptor Antagonism (2008) (33)
Prediction of Long‐Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15‐Year Prospective Follow‐Up Study (2010) (33)
Reduction of atrial natriuretic factor circulating levels by endogenous sympathetic activation in hypertensive patients. (1988) (33)
Atrial natriuretic factor potentiates forearm reflex vasoconstriction induced by cardiopulmonary receptor deactivation in man. (1988) (32)
Impact of Fasting Glycemia and Regional Cerebral Perfusion in Diabetic Subjects: A Study With Technetium-99m-Ethyl Cysteinate Dimer Single Photon Emission Computed Tomography (2009) (32)
Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failure. (2011) (32)
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study (2009) (31)
Epigenetics and cardiovascular regenerative medicine in the elderly. (2018) (31)
Fewer mega-trials and more clinically oriented studies in hypertension research? The case of blocking the renin-angiotensin-aldosterone system. (2006) (31)
Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications. (2010) (31)
A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort (2016) (31)
Antihypertensive Therapy in Diabetes: The Legacy Effect and RAAS Blockade (2011) (31)
Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians (2009) (31)
A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. (2005) (31)
Hemodynamic Responses (2005) (31)
Transient enhancement of sympathetic nervous system activity by long-term restriction of sodium intake. (1985) (31)
Calcium Channel Blockers and Hypertension (2015) (30)
Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study (2010) (30)
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design (2013) (30)
Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats. (1997) (30)
Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension. (2003) (29)
Hypertension, a Moving Target in COVID-19: Current Views and Perspectives (2021) (29)
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation (2020) (29)
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS) (2009) (28)
Is reactivation of autophagy a possible therapeutic solution for obesity and metabolic syndrome? (2012) (28)
Valsalva maneuver in the assessment of baroreflex responsiveness in borderline hypertensives. (1983) (28)
Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors. (2013) (28)
Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies. (2013) (27)
Osteopontin and Galectin‐3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators (2014) (27)
Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic (2012) (27)
Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study (2013) (27)
Impaired responsiveness of the ventricular sensory receptor in hypertensive patients with left ventricular hypertrophy. (1986) (27)
Mitochondrial Dysfunction Contributes to Hypertensive Target Organ Damage: Lessons from an Animal Model of Human Disease (2016) (27)
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics (2019) (27)
Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension An Open-Label, Long-Term Study (2009) (27)
The autonomic nervous tone abnormalities in the genesis of the impaired baroreflex responsiveness in borderline hypertensive subjects. (1982) (27)
Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes. (2015) (26)
Abnormal Hormonal and Renal Responses to Saline Load in Hypertensive Patients With Parental History of Cardiovascular Accidents (1991) (26)
Salt‐Induced Plasticity in Cardiopulmonary Baroreceptor Reflexes in Salt‐Resistant Hypertensive Patients (1991) (26)
Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension. (1984) (26)
Reciprocal congenic lines for a major stroke QTL on rat chromosome 1. (2006) (26)
Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat (2017) (26)
Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases. (2014) (26)
Radionuclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Effects of angiotensin-converting enzyme inhibition. (1995) (25)
Increased cardiac output and lowered peripheral resistance during metoprolol treatment. (2009) (25)
Effects of Celiprolol on Systemic and Forearm Circulation in Hypertensive Patients: A Double‐Blind Cross‐Over Study Versus Metoprolol (1987) (25)
ARB-Based Single-Pill Platform to Guide a Practical Therapeutic Approach to Hypertensive Patients (2014) (25)
Human coronary atherosclerosis modulates cardiac natriuretic peptide release. (2009) (25)
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project (2021) (25)
Hypertension Control and Cardiometabolic Risk: A Regional Perspective (2012) (25)
Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPAR&agr;/UCP2 axis (2015) (25)
Admission heart rate and in-hospital course of patients with Takotsubo syndrome. (2018) (24)
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study (2012) (24)
Atrial natriuretic peptide and the baroreflex control of circulation. (1992) (24)
ARNi: A Novel Approach to Counteract Cardiovascular Diseases (2019) (24)
Might renin–angiotensin system blockers play a role in the COVID-19 pandemic? (2020) (24)
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study (2020) (24)
The importance of endothelial dysfunction in resistance artery remodelling and cardiovascular risk. (2019) (24)
Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension (2009) (24)
Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions (2019) (24)
Renal artery stenosis detection by combined Gates' technique and captopril test in hypertensive patients. (1989) (24)
Forearm vascular responsiveness to alpha 1- and alpha 2-adrenoceptor stimulation in patients with congestive heart failure. (1994) (24)
Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease. (2016) (23)
100% Fruit juice intake and cardiovascular risk: a systematic review and meta-analysis of prospective and randomised controlled studies (2020) (23)
Use of aliskiren in a ‘real-life’ model of hypertension management: analysis of national Web-based drug-monitoring system in Italy (2011) (23)
Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains (2015) (23)
Managing cardiovascular risk: the need for change (2008) (23)
Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice (2010) (23)
Angiotensin II AT2 subtype receptors: an emerging target for cardiovascular therapy. (2000) (23)
Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension (2012) (22)
Natriuretic peptides in heart failure: Current achievements and future perspectives. (2019) (22)
Association of physicians’ accuracy in recording with quality of care in cardiovascular medicine (2009) (22)
The Role of Dihydropyridine Calcium Channel Blockers in the Treatment of Hypertension and Cardiovascular Disease - An Update (2006) (22)
Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis. (2016) (22)
Beta blockers and left ventricular hypertrophy in hypertension. (1987) (22)
Renin as a biomarker of cardiovascular disease in clinical practice. (2012) (22)
Angiotensin II-induced atrial natriuretic factor release in dogs is not related to hemodynamic responses. (1990) (22)
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy. (2017) (22)
Differential brain atrial natriuretic peptide expression co-segregates with occurrence of early stroke in the stroke-prone phenotype of the spontaneously hypertensive rat. (1999) (22)
Management of hypertension and stroke prevention: results of the Italian cardiologist survey (2009) (21)
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk (2021) (21)
Role of oxidative stress in the process of vascular remodeling following coronary revascularization. (2018) (21)
Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro (2009) (21)
Differential Regulation of Epstein-Barr Virus (EBV) Latent Gene Expression in Burkitt Lymphoma Cells Infected with a Recombinant EBV Strain (2001) (21)
Non-invasive diagnostic testing for coronary artery disease in the hypertensive patient: potential advantages of a risk estimation-based algorithm. (2012) (21)
Hypertension, a Moving Target in COVID-19 (2021) (21)
Relation between right and left ventricular function in patients undergoing chronic dialysis (2013) (20)
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter‐Defibrillator in Patients with Hypertrophic Cardiomyopathy (2014) (20)
Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure. (2000) (20)
Effects of high-cholesterol and atherogenic diets on vascular relaxation in spontaneously hypertensive rats. (1997) (20)
Hypertension as an Underlying Factor in Heart Failure With Preserved Ejection Fraction (2010) (20)
Evaluation of systolic properties in hypertensive patients with different degrees of diastolic dysfunction and normal ejection fraction. (2009) (20)
β2-Adrenergic Receptor Gene Polymorphisms and Risk of Ischemic Stroke* (2007) (20)
Renal Artery Denervation for Treating Resistant Hypertension (2012) (20)
Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in elderly hypertensive patients: pooled individual data analysis of two randomized, double-blind, parallel-group studies (2012) (20)
Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study (2014) (20)
Midwall LV mechanics in rats with or without renovascular hypertension: effect of different Na+ intakes. (1996) (20)
Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans (2007) (20)
Erythropoietin in cardiac disease: effective or harmful? (2013) (19)
Managing hypertension in cardiology practice according to risk profile (2008) (19)
Physicians, patients, and public knowledge and perception regarding hypertension and stroke: a review of survey studies (2006) (19)
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022) (19)
Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey. (2009) (19)
Tortuosity, Recurrent Segments, and Bridging of the Epicardial Coronary Arteries in Patients With the Takotsubo Syndrome. (2017) (19)
Pulmonary embolism in pregnancy (2014) (19)
Role of prostaglandins in the renal handling of a salt load in essential hypertension. (1985) (19)
Reducing Cardiovascular and Cancer Risk: How to Address Global Primary Prevention in Clinical Practice (2015) (19)
Unexpectedly Low Mutation Rates in Beta-Myosin Heavy Chain and Cardiac Myosin Binding Protein Genes in Italian Patients With Hypertrophic Cardiomyopathy (2011) (19)
Dietary salt excess unmasks blunted aldosterone suppression and sodium retention in the stroke-prone phenotype of the spontaneously hypertensive rat (1993) (19)
A guide for easy- and difficult-to-treat hypertension. (2014) (19)
The Changing Role of Hypertension Societies (2012) (19)
Novel antidiabetic drugs and cardiovascular risk: Primum non nocere. (2016) (19)
Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function. (1989) (19)
Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy (2015) (19)
Treatment of systolic hypertension: spotlight on recent studies with angiotensin II antagonists (2005) (19)
Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option? (2008) (18)
Effects of a Long-Term Treatment With Aliskiren or Ramipril on Structural Alterations of Subcutaneous Small-Resistance Arteries of Diabetic Hypertensive Patients (2014) (18)
Should all patients at high cardiovascular risk receive renin-angiotensin system blockers? (2012) (18)
Late phase of nitroglycerin-induced coronary vasodilatation blunted by inhibition of prostaglandin synthesis. (1985) (18)
Characterization of caveolae from rat heart: Localization of postreceptor signal transduction molecules and their rearrangement after norepinephrine stimulation (2000) (18)
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy (2018) (18)
Attenuated IGF-1 predicts all-cause and cardiovascular mortality in a Black population: A five-year prospective study (2016) (18)
Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits. (1991) (18)
Cerebrovascular disease in women. (2002) (18)
Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know (2019) (17)
Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass. (1988) (17)
Multivariate risk assessment and risk score cards in hypertension (2007) (17)
Blood Pressure Targets Achievement According to 2018 ESC/ESH Guidelines in Three European Excellence Centers for Hypertension (2020) (17)
Ferrari Corporate Wellness Program: Results of a Pilot Analysis and the “Drag” Impact in the Workplace (2018) (17)
In vitro characterization of mitochondrial function and structure in rat and human cells with a deficiency of the NADH: ubiquinone oxidoreductase Ndufc2 subunit (2017) (17)
Prolonged duration of myocardial ischemia in patients with coronary heart disease and impaired cardiopulmonary baroreceptor sensitivity. (1990) (17)
Treatment priorities and current prescribing patterns in hypertension: results of GRASP, an international physician survey (2004) (17)
Simultaneous Takotsubo syndrome in two sisters. (2013) (17)
Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat (2018) (17)
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study (2020) (17)
Has the SPRINT trial introduced a new blood-pressure goal in hypertension? (2017) (17)
P‐Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension (2015) (17)
The REassessment of Antihypertensive Chronic Therapy (REACT) Study (2004) (16)
Prevalence of metabolic syndrome in the clinical practice of general medicine in Italy. (2015) (16)
Metabolic Syndrome (2015) (16)
ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations? (2002) (16)
Rac1 Pharmacological Inhibition Rescues Human Endothelial Dysfunction (2017) (16)
Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination (2012) (16)
Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy. (2018) (16)
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum? (2012) (16)
Adding markers of organ damage to risk score models improves cardiovascular risk assessment: Prospective analysis of a large cohort of adult outpatients. (2017) (16)
Redefining blood pressure targets in high-risk patients?: lessons from coronary endpoints in recent randomized clinical trials. (2011) (16)
Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome: results from the international multicenter GEIST registry (2020) (16)
Pregnancy-associated plasma protein-A and acute coronary syndromes: cause or consequence? (2005) (15)
Gender Differences in Takotsubo Syndrome. (2022) (15)
Prognostic relevance of GRACE risk score in Takotsubo syndrome (2020) (15)
Stable improvement in large artery compliance after long-term antihypertensive treatment with enalapril. (1988) (15)
Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform (2017) (15)
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. (1996) (15)
Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway (2017) (15)
Understanding and treating hypertension in diabetic populations. (2015) (15)
Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients. (1994) (15)
A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines (2017) (15)
Effects of atrial natriuretic factor on human platelet function. (1985) (15)
Effects of losartan treatment on cardiac autonomic control during volume loading in patients with DCM. (2000) (15)
Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension (2018) (15)
Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension (2020) (15)
Hemodynamic Responses to Atrial Natriuretic Factor in Nephrectomized Rabbits: Attenuation of the Circulatory Consequences of Acute Volume Expansion (1988) (15)
Association of a single nucleotide polymorphism of the NPR3 gene promoter with early onset ischemic stroke in an Italian cohort. (2013) (15)
Global Cardiovascular Risk Assessment in Different Clinical Settings (2009) (15)
Contribution of the renin-angiotensin system and of the sympathetic nervous system to blood pressure homeostasis during chronic restriction of sodium intake. (1988) (14)
In the search for stroke genes: a long and winding road. (2004) (14)
Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease. (2014) (14)
Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient (2020) (14)
Use of Electronic Support for Implementing Global Cardiovascular Risk Management (2010) (14)
Baroreflex responsiveness in borderline hypertensives: a study with neostigmine. (1981) (14)
Cardiovascular disease in women with HIV-1 infection. (2017) (14)
Prevalence and Control of Hypertension in Different Macro-Areas in Italy: Analysis of a Large Database by the General Practice (2016) (14)
Effect of atrial natriuretic factor on renin secretion, plasma renin and aldosterone in dogs with acute unilateral renal artery constriction. (1985) (14)
Relation of left ventricular hypertrophy, afterload, and contractility to left ventricular performance in Goldblatt hypertension. (1992) (14)
Clinical Management of Patients with Hypertension and High Cardiovascular Risk (2014) (14)
OF CEREBRAL VENTRICULAR ENLARGEMENT IN SCHIZOPHRENIA (1985) (14)
Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome? (2020) (14)
Reduction in estimated stroke risk associated with practice-based stroke-risk assessment and awareness in a large, representative population of hypertensive patients: results from the ForLife study in Italy (2007) (14)
Reclassification of Hypertensive Outpatients According to New US Guidelines on High Blood Pressure (2018) (14)
Effect of a regulatory mutation on the rat atrial natriuretic peptide gene transcription (2002) (14)
Relationship between systolic time intervals and heart rate during atrial or ventricular pacing in normal subjects. (1980) (14)
Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan (2018) (14)
Global cardiovascular risk management in different Italian regions: an analysis of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation (EFFECTUS) educational program. (2012) (14)
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention (2020) (13)
New approach to blood pressure control: Triple combination pill. (2020) (13)
Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension (2007) (13)
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence. (2020) (13)
The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome. (2019) (13)
Impact of Diabetes Mellitus on the Clinical Management of Global Cardiovascular Risk: Analysis of the Results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) Educational Program (2011) (13)
Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy (2017) (13)
Arterial Hypertension and Cardiac Damage (2008) (13)
Long-Term Outcome of Acute Coronary Syndromes in Young Patients (2017) (13)
Analysis of the genetic basis of the endothelium‐dependent impaired vasorelaxation in the stroke‐prone spontaneously hypertensive rat: a candidate gene approach (2000) (13)
Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes (2018) (13)
Impaired control of vasopressin release in hypertensive subjects with cardiac hypertrophy. (1987) (13)
Coronavirus disease 2019 in patients with cardiovascular disease: clinical features and implications on cardiac biomarkers assessment (2021) (13)
Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension (2020) (13)
Impaired vasorelaxant responses to natriuretic peptides in the stroke‐prone phenotype of spontaneously hypertensive rats (1998) (13)
Rilmenidine in Patients with Left Ventricular Hypertrophy: Beyond the Reduction of Left Ventricular Mass (1995) (13)
Quality improvement of medical records through internal auditing: a comparative analysis (2019) (13)
A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians (2007) (12)
The REACT Study (2004) (12)
An interplay between UCP2 and ROS protects cells from high-salt-induced injury through autophagy stimulation (2021) (12)
A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat (2017) (12)
Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy (2010) (12)
Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine (2009) (12)
Effect of furosemide on plasma concentration and β‐blockade by propranolol (1979) (12)
Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic (2021) (12)
A Novel Electrocardiographic T‐Wave Measurement (Tp‐Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First‐Line Electrocardiographic Evaluation (2015) (12)
Direct Renin Inhibition (2011) (12)
Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease. (2011) (12)
The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes. (2013) (12)
Influence of hypercholesterolemia on adrenal steroid metabolism and electrolyte balance in spontaneously hypertensive rats. (1993) (12)
Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protection (2013) (12)
A survey on blood pressure levels and hypertension control in a sample of the Italian general population. (2012) (12)
Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study. (2012) (12)
Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis. (2017) (12)
Does clinical governance influence the appropriateness of hospital stay? (2015) (12)
Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort. (2011) (11)
Olmesartan in the Treatment of Hypertension in Elderly Patients: a Review of the Primary Evidence (2013) (11)
NT-proANP circulating level is a prognostic marker in stable ischemic heart disease. (2012) (11)
Novel Insights Into the Mechanisms Regulating Pro-Atrial Natriuretic Peptide Cleavage in the Heart and Blood Pressure Regulation: Proprotein Convertase Subtilisin/Kexin 6 Is the Corin Activating Enzyme. (2016) (11)
Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: A contemporary meta-analysis. (2020) (11)
Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)—Lessons learned for losartan: An “old dog playing good tricks” (2018) (11)
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil (2012) (11)
Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure (2013) (11)
The cardiovascular continuum refined: A hypothesis (2010) (11)
Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA) (2021) (11)
Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan (2012) (11)
Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing (2020) (11)
Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum (2021) (11)
High Blood Pressure & Cardiovascular Prevention (2007) (11)
Transfemoral approach with systematic use of FemoSeal™ closure device compared to transradial approach in primary angioplasty (2016) (11)
NEUROADRENERGIC PROFILE IN PATIENTS WITH RESISTANT HYPERTENSION: 9C.03 (2011) (11)
Cardiovascular Prevention in Subjects with Impaired Fasting Glucose or Impaired Glucose Tolerance (2010) (11)
Implications of Guidelines for Hypertension Management in Europe. (2019) (11)
Longitudinal changes of left and right cardiac structure and function in patients with end-stage renal disease on replacement therapy. (2020) (11)
Reflex control of coronary vascular tone by cardiopulmonary receptors in humans. (1988) (11)
Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysm. (2015) (11)
INVERTED RESPONSE OF ARGININE VASOPRESSIN TO POSTURAL CHANGE IN PATIENTS WITH ESSENTIAL HYPERTENSION (1982) (11)
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy. (2018) (11)
Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals. (2019) (10)
Cardiovascular effects of synthetic atrial natriuretic factor (ANF) in normal dogs (1985) (10)
Olmesartan vs. Ramipril in Elderly Hypertensive Patients: Review of Data from Two Published Randomized, Double-Blind Studies (2014) (10)
Hypertension in the elderly: which are the blood pressure threshold values? (2019) (10)
Depression is associated with increased occurrence of left ventricle concentric geometry in older subjects independently of blood pressure levels. (2011) (10)
Antihypertensive therapy and cerebrovascular protection (2006) (10)
Transition from asymptomatic left ventricular dysfunction to congestive heart failure. (1995) (10)
End-Organ Protection in Patients with Hypertension (2011) (10)
Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT1 receptors in renin transgenic rats. (1995) (10)
Angiotensin receptor modulation and cardiovascular remodeling (2011) (10)
Rheological leukocyte indexes in diabetes mellitus type II. (1992) (10)
A systematic review on focal takotsubo syndrome: a not-so-small matter (2020) (10)
Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH (2010) (10)
Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth Factor (2018) (10)
The C2238/αANP Variant Is a Negative Modulator of Both Viability and Function of Coronary Artery Smooth Muscle Cells (2014) (10)
C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro (2015) (10)
Relationship Between Cardiorespiratory Fitness, Baseline Blood Pressure and Hypertensive Response to Exercise in the Ferrari Corporate Population (2021) (10)
Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome (2012) (10)
The management of the type 2 diabetic patient with hypertension – too late and too little: Suggested improvements (2008) (10)
QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal. (2017) (10)
Favourable impact of statin use on diastolic blood pressure levels: analysis of a large database of 24-hour ambulatory blood pressure monitoring (2017) (10)
Pathophysiology of biventricular dysfunction during hemodialysis: emerging concepts. (2012) (9)
Cardiac autonomic responses to volume overload in normal subjects and in patients with dilated cardiomyopathy. (1999) (9)
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan (2018) (9)
Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. (2008) (9)
Role of a molecular variant of rat atrial natriuretic Peptide gene in vascular remodeling. (2007) (9)
Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension (2014) (9)
Triple combination therapy to improve blood pressure control: experience with olmesartan–amlodipine–hydrochlorothiazide therapy (2012) (9)
Nitric oxide release is impaired in hypertensive individuals with familial history of stroke. (2006) (9)
Cardiac magnetic resonance evaluation of the impact of interventricular and intraventricular dyssynchrony on cardiac ventricular systolic and diastolic function in patients with isolated left bundle branch block. (2012) (9)
Influence of O2 deprivation, reduced flow, and temperature on release of ANP from rabbit hearts. (1995) (9)
Plasma Renin and Cardiovascular Risk: What Is the Evidence for an Association? (2013) (9)
Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study (2016) (9)
The neglected issue of cardiac amyloidosis in trials on heart failure with preserved ejection fraction in the elderly (2020) (9)
Amlodipine/Valsartan Single-Pill Combination A Review of its Use in the Management of Hypertension (2009) (9)
Angiotensin II receptor blockers and coronary artery disease: 'presumed innocents'. (2005) (9)
Pathophysiological Implications in Obesity and Metabolic Syndrome Rheb is a Critical Regulator of Autophagy During Myocardial Ischemia : (2012) (8)
Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study (2021) (8)
Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk (2017) (8)
Impact of Hypertension on Global Cardiovascular Risk Stratification: Analysis of a Large Cohort of Outpatient Population in Italy (2015) (8)
Clinical Management of Resistant Hypertension (2013) (8)
T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients (2016) (8)
Effects of disodium cromoglycate on hypoxic pulmonary hypertension in dogs. (1979) (8)
Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey (2014) (8)
Angiotensin Receptor Antagonists to Prevent Sudden Death in Heart Failure: Does the Dose Matter? (2014) (8)
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era (2021) (8)
Histamine and hypoxic pulmonary hypertension. A quantitative study. (1978) (8)
Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. (1980) (8)
Beta2-adrenergic receptor gene polymorphisms and risk of ischemic stroke. (2007) (8)
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines (2015) (8)
Molecular mechanisms of cardiac hypertrophy (1998) (8)
Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH (2012) (8)
An Analysis of the Management of Cardiovascular Risk Factors in Routine Clinical Practice in Italy (2011) (8)
Therapeutic implications of recent megatrials in hypertension: in favor of new drugs. (2007) (8)
2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document (2017) (8)
The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases (2018) (8)
Overview of the i-SEARCH Global Study (2008) (8)
The association of uric acid with mortality modifies at old age: data from the uric acid right for heart health (URRAH) study (2021) (8)
Real-World Hypertension Prevalence, Awareness, Treatment, and Control in Adult Diabetic Individuals: An Italian Nationwide Epidemiological Survey (2021) (7)
Effects of Chronic Antihypertensive Treatment with Ketanserin Versus Metoprolol on Blood Pressure and Large Arteries' Compliance in Humans: A Cross‐Over Double‐Blind Study (1988) (7)
NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. (2016) (7)
Ouabain-induced reflex coronary vasodilatation mediated by cardiac receptors. (1984) (7)
Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy (2018) (7)
Renal function in borderline hypertensive first-degree relatives of essential hypertensives. Effects of sodium load. (1982) (7)
Carotid sinus reflex control of coronary blood flow in human subjects. (1985) (7)
Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat (2000) (7)
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. (2014) (7)
Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike? (2021) (7)
[Audit as a tool to assess and promote the quality of medical records and hospital appropriateness: metodology and preliminary results]. (2015) (7)
Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project. (2022) (7)
Clinical characteristics of patients with takotsubo syndrome recurrence: An observational study with long-term follow-up. (2020) (7)
Trehalose, a natural disaccharide, reduces stroke occurrence in the stroke-prone spontaneously hypertensive rat. (2021) (7)
Angiotensin II: An amplifier of cardiovascular risk (2004) (7)
Genetic Susceptibility to Cerebrovascular Accidents (2001) (7)
Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention (2022) (7)
Molecular and clinical implications of natriuretic peptides in aortic valve stenosis. (2019) (7)
Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From? (2019) (7)
Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy (2019) (7)
Effects of coronary occlusion on arterial baroreflex control of heart rate and vascular resistance. (1987) (7)
Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome (2018) (7)
The EMPEROR-Preserved study: end of the search for the "Phoenix" or beginning of a new season for trials in heart failure with preserved ejection fraction. (2021) (7)
Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients (2021) (7)
Long-Term Tolerability and Efficacy of the Fixed Combination of Manidipine and Delapril in Patients with Essential Hypertension (2003) (7)
Effects of oral salt loading on beta-adrenergic receptor responsiveness in normal and hypertensive subjects. (1982) (7)
Blood Pressure Target Achievement Under Monotheraphy: A Real-Life Appraisal (2020) (7)
Non-random chromosomal distribution of SSLPs: systematic assessment using a novel genetic linkage map between two closely related rat strains (2001) (7)
Forearm Vascular Responsiveness to α1‐ and α2‐Adrenoceptor Stimulation in Patients With Congestive Heart Failure (1994) (7)
Synergistic beneficial effects of natural activators of autophagy on endothelial cells and platelets. (2021) (7)
24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity (2018) (7)
Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention (2015) (6)
Cost analysis for deliveries according to maternal age classes for moving to a personalized approach in the health care (2019) (6)
Atrial Natriuretic Peptide Single Nucleotide Polymorphisms in Patients with Nonfamilial Structural Atrial Fibrillation (2013) (6)
Atrial natriuretic factor (auriculin): structure and biological effects. (1985) (6)
The case for blood pressure control in risk groups (2004) (6)
NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis. (2013) (6)
Arterial Stiffness and Cognitive Impairment in the Elderly (2007) (6)
Rethinking targets of blood pressure and guidelines for hypertension clinical management. (2010) (6)
Natural History of Treated and Untreated Hypertension (2018) (6)
Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire (2015) (6)
T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients (2018) (6)
Aldosterone receptor antagonism in patients with diabetes and chronic kidney disease: new promises and old problems. (2020) (6)
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]. (2018) (6)
Influence of volume expansion on hemodynamic effects of atrial natriuretic factor in rabbits. (1989) (6)
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company (2021) (6)
Legacy Effect in the Treatment of Hypertension: Persistent Cardiovascular Protection after Conclusion of Randomized Clinical Trials in Hypertension (2019) (6)
Relationships between left ventricular mass and clinical, biohumoral and hemodynamic parameters in human hypertension. (1984) (6)
Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status: A retrospective analysis (2012) (6)
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP (2017) (6)
Digitalis restores the forearm sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy (1993) (6)
Inflammatory residual risk: An emerging target to reduce cardiovascular disease? (2018) (6)
Olmesartan medoxomil for the treatment of hypertension in children and adolescents (2011) (6)
Cardiovascular Risk Profile in 14 513 Patients with Essential Hypertension Followed by Italian Specialist Physicians (2004) (6)
Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy. (2010) (6)
An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy. (2012) (6)
Indenolol: A New Antihypertensive Agent: Efficacy, Toxicity, and Hemodynamic Effects in a Crossover Double‐Blind Study With Metoprolol (1985) (6)
Genetic basis of cerebrovascular accidents associated with hypertension. (1999) (6)
A Survey on Blood Pressure Levels and Hypertension Control in a Sample of the Italian General Population (2012) (6)
Hypertension Across the Atlantic: A Sprint or a Marathon? (2017) (6)
Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease (2016) (6)
The clinical relevance of dysfunctional HDL in patients with coronary artery disease: a 3-year follow-up study. (2012) (6)
Conventional and new electrocardiographic criteria for hypertension‐mediated cardiac organ damage: A narrative review (2019) (6)
Hypertension and Heart Failure: Role of Neurohormonal Mechanisms (2004) (6)
National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities (2014) (6)
Antihypertensive Efficacy of Olmesartan Medoxomil and Ramipril in Elderly Patients with Mild to Moderate Hypertension Grouped According to Renal Function Status (2012) (6)
An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients (2012) (6)
Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19 (2020) (5)
Attitudes and preferences for the clinical management of hypertension and hypertension-related cerebrovascular disease in the general practice: results of the Italian hypertension and brain survey (2017) (5)
Early echocardiographic modifications after flow reduction by proximal radial artery ligation in patients with high-output heart failure due to high-flow forearm arteriovenous fistula (2020) (5)
Preclinical effects of healthy obesity on inappropriate left ventricular mass and systolic function. (2013) (5)
[Role of adherence to long-term drug therapy in patients with cardiovascular disease: an Italian intersocietary consensus document]. (2014) (5)
Inhibition of miR‐155 Attenuates Detrimental Vascular Effects of Tobacco Cigarette Smoking (2020) (5)
May Measurement Month 2019: an analysis of blood pressure screening results from Italy (2021) (5)
The physiological role of atrial natriuretic factor. (1992) (5)
Functional Role of Natriuretic Peptides in Risk Assessment and Prognosis of Patients with Mitral Regurgitation (2020) (5)
Tales in Cardiology. (2019) (5)
Angiotensin II-receptor antagonist in the treatment of hypertension (2005) (5)
Is there a relationship between health care models and their performance assessment? The results of an extensive review (2008) (5)
Echocardiographic assessment of the effect of a long-term treatment with metoprolol on the left ventricle in hypertensive patients (1980) (5)
The emotional and social burden of heart failure: integrating physicians’, patients’, and caregivers’ perspectives through narrative medicine (2020) (5)
Effects of different statin types and dosages on systolic/diastolic blood pressure: Retrospective analysis of 24‐hour ambulatory blood pressure database (2018) (5)
Extracellular Matrix Remodelling in Myocardial Hypertrophy and Failure (2009) (5)
Neurological state, infarct size and clinical outcome are related to early platelet count decrease in stroke. (1993) (5)
Hypertension therapy: Mixing, matching, and meeting targets (2004) (5)
[Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension]. (2012) (5)
Hormonal profile in mild heart failure. (1993) (5)
Beneficial effects of a combination of natural product activators of autophagy on endothelial cells and platelets (2021) (5)
Natriuretic Peptides, Cognitive Impairment and Dementia: An Intriguing Pathogenic Link with Implications in Hypertension (2020) (5)
Integrated Preclinical Cardiovascular Prevention: A New Paradigm to Face Growing Challenges of Cardiovascular Disease (2015) (5)
New Opportunities for Monitoring Blood Pressure Control and Awareness in the Population: Insights from 12-Year Editions of the World Hypertension Day (2016) (5)
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]. (2021) (5)
Integrated cardiovascular risk management for the future: lessons learned from the ASCOT trial. (2005) (5)
Amiodarone induced siadh: A case of rare and late onset side effects (2015) (5)
COVID-19 and the Forgotten Majority (2020) (5)
The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile. (2021) (5)
Endocrine function of the heart in cardiac disease. (1989) (5)
Role of Genetic Factors in the Etiopathogenesis of Cerebrovascular Accidents: From an Animal Model to the Human Disease (2004) (5)
2008 White Paper for Implementing Strategies and Interventions for Cardiovascular Prevention in Italy (2008) (5)
Chronic Kidney Disease in the Hypertensive Patient (2011) (5)
Antihypertensive drugs and the risk of cancer: a critical review of available evidence and perspective. (2020) (5)
Clinical Management of Coronary Heart Disease in Hypertension (2013) (5)
&agr;2A-Adrenergic Receptor Polymorphism Potentiates Platelet Reactivity in Patients With Stable Coronary Artery Disease Carrying the Cytochrome P450 2C19*2 Genetic Variant (2014) (5)
Identification of adrenomedullin as a candidate gene in the stroke-prone phenotype of spontaneously hypertensive rats (SHRSP) (1998) (5)
Animal models of genetic hypertension: what can we learn for human hypertension? (1995) (5)
Natriuretic peptides and volume handling in heart failure: the paradigm of a new treatment (2016) (5)
Carotid baroreceptor unloading decreases plasma atrial natriuretic factor in hypertensive patients. (1986) (5)
Shooting vascular oxidative stress: new hopes for stroke patients? (2015) (5)
1,5-disubstituted-1,2,3-triazoles counteract mitochondrial dysfunction acting on F1FO-ATPase in models of cardiovascular diseases. (2022) (4)
I-CARE: Individual activation of people with dementia (2016) (4)
Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy (2011) (4)
CARDIOVASCULAR DEATH RISK IN RECOVERED MID-RANGE EJECTION FRACTION HEART FAILURE: INSIGHTS FROM CARDIOPULMONARY EXERCISE TEST. (2020) (4)
Effects of atrial natriuretic peptide on glomerular filtration rate in essential hypertension: a radionuclide study (2004) (4)
Do VERTIS-CV trial results question a class-effect of cardiovascular protection with sodium-glucose cotransporter 2 inhibitors? (2020) (4)
Diagnosis and treatment of resistant hypertension (2014) (4)
Antihypertensive effect and end-organ protection of flavonoids: some insights, more questions. (2002) (4)
Circulating NT-proANP level is a predictor of mortality for systemic sclerosis: a retrospective study of an Italian cohort (2021) (4)
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid. (2021) (4)
The REDUCE-IT verdict on eicosapentaenoic acid and cardiovascular outcome challenged with STRENGTH. (2020) (4)
Cardiovascular Risk Management in Clinical Practice (2008) (4)
Erratum to: ARB-Based Single-Pill Platform to Guide a Practical Therapeutic Approach to Hypertensive Patients (2014) (4)
Prevalence of ‘Borderline’ Values of Cardiovascular Risk Factors in the Clinical Practice of General Medicine in Italy (2011) (4)
Altered regulation of endothelin A receptor subtype in the cerebral arterioles in response to a Japanese-style diet, in stroke-prone hypertensive rats (2003) (4)
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control (2017) (4)
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits (2019) (4)
Prevention of cardiorenal damage: importance of albuminuria. (2022) (4)
To whom recommend intensive treatment for hypertension? (2020) (4)
Tailored angiogenesis inhibition in cancer therapy: Respecting the heart to improve the net outcome (2012) (4)
Hypertensive crisis management in the emergency room: time to change? (2020) (4)
[Activation of the renin-angiotensin-aldosterone system in heart failure]. (2005) (4)
Angiotensin receptor blockers and myocardial infarction: the importance of dosage (2006) (4)
Global cardiovascular risk management in primary prevention. (2012) (4)
Clinical evaluation of the antiarrhythmic properties of intravenously administered mexiletine: Efficacy comparison with lidocaine in a crossover randomized trial (1981) (4)
Is there any memory effect of blood pressure lowering in diabetes? (2011) (4)
2010 Position Paper of the Italian Society of Hypertension (SIIA) (2011) (4)
Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project (2021) (4)
Endothelial dysfunction and genetic predisposition to stroke in spontaneously hypertensive rats (1998) (4)
Functional assessment of coronary atherosclerosis in the catheterization laboratory: the key role of fractional flow reserve. (2005) (4)
The Apelin/APJ System (2006) (4)
Endocrine functions of the heart: from bench to bedside. (2022) (4)
Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man (2012) (4)
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) (4)
Novel ANP (Atrial Natriuretic Peptide)-Based Therapy for Hypertension: The Promising Role of a Disease Mechanism Targeted Approach. (2021) (4)
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome (2021) (4)
Hypovitaminosis D and Organ Damage In Patients With Arterial Hypertension: A Multicenter Double Blind Randomised Controlled Trial of Cholecalciferol Supplementation (HYPODD) (2015) (4)
Myocarditis after BNT162b2 mRNA SARS-CoV-2 vaccine: low incidence and mild severity (2022) (4)
Clinical management of patients with hypertension and high cardiovascular risk in specialised centers and in general practice. Analysis from an Italian Survey Questionnaire. (2015) (4)
Angiotensin II-Linked Hypothesis to Understand the Advantage of the Coevolution of Hypertension and Malaria: "Sympathy for the Devil". (2016) (4)
Cardiovascular Risk in Hypertension - Can We Ask for More? (2008) (4)
A New Option for Therapeutic Management of Patients with Cardiovascular Disease (2008) (4)
Determinants of healing among patients with COVID-2019: the results of the SARS-RAS study of the Italian Society of Hypertension (2020) (4)
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control (2017) (4)
Old and novel insights into emergency peripartum hysterectomy: a time-trend analysis (2020) (4)
LONG-TERM CARE QUALITY ASSURANCE POLICIES IN EUROPEAN COUNTRIES. ENEPRI RESEARCH REPORT NO. 111 (2012) (4)
The importance of clinical audit: a comparative analysis of quality of medical records (2014) (4)
Long-Term Care Quality Assurance Policies in the European Union. ENEPRI Research Report No. 111, March 2012 (2012) (4)
Hypertensive Patients With Left Ventricular Hypertrophy (2005) (4)
Novel blood pressure targets in patients with high-normal levels and grade 1 hypertension: Room for monotherapy? (2019) (4)
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. (2008) (4)
Cardiometabolic phenotype of heart failure with preserved ejection fraction as a target of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide receptor agonists (2020) (3)
Ventriculo-arterial coupling in the intensive cardiac care unit: A non-invasive prognostic parameter (2021) (3)
Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy. (2021) (3)
[Effects of salt loading on the response to isoproterenol in normal and hypertensive subjects]. (1982) (3)
[Polytherapy in cardiovascular prevention: open issues]. (2012) (3)
Modern Clinical Management of Arterial Hypertension (2011) (3)
An easy and reproducible parameter for the assessment of the pressure gradient in patients with aortic stenosis disease: A magnetic resonance study. (2015) (3)
Evidence-Based Indications in Hypertensive Patients (2004) (3)
Management of risk factors in vascular dementia: hypertension (2008) (3)
FIGARO-DKD adds new evidence to the cardiovascular benefits of finerenone across the spectrum of patients with type 2 diabetes and chronic kidney disease (2021) (3)
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension (2011) (3)
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology. (2022) (3)
Abstract 18096: Trehalose, a Natural Dissacharide, Reduces Cardiac Remodeling After Myocardial Infarction Through Autophagy Activation (2012) (3)
Histamine mediation in muscular vasodilatation induced by beta adrenoceptor stimulation in dogs. (1977) (3)
Acute hemodynamic effects of atrial natriuretic peptide in essential hypertension. (1988) (3)
LONG-TERM CARE QUALITY ASSURANCEPOLICIES IN EUROPEAN COUNTRIES (2012) (3)
An atypical clinical presentation of renovascular hypertension. (2014) (3)
NT-proANP/ANP is a Determinant of Vascular Damage in Humans (2010) (3)
Capturing the chance for pneumococcal vaccination in the hospital setting. (2017) (3)
A randomized trial supports the recommendation to continue treatment with ACEi or ARBs during hospitalization for COVID-19 (2021) (3)
Protocol for an Observational Blood Pressure Study (2004) (3)
Outcomes of early invasive treatment strategy in elderly patients with non-ST elevation acute coronary syndromes (2016) (3)
An evolutionary rebus: the complex link between malaria and hypertension. (2019) (3)
Effects of Olmesartan on Endothelial Function (2007) (3)
Does Clinical Governance influence the quality of medical records? (2018) (3)
Breath tests sustainability in hospital settings: cost analysis and reimbursement in the Italian National Health System. (2013) (3)
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice. (2021) (3)
‘QRS duration and QRS fractionation on surface electrocardiogram are markers of right ventricular dysfunction and atrialization in patients with Ebstein anomaly’ [Eur Heart J 2012;34:191–200, doi:10.1093/eurheartj/ehs362] (2013) (3)
[Surgical treatment of ovarian cysts: economic analysis as a means for the evaluation of alternative technics. Results of a biennial study]. (1996) (3)
Antihypertensive drugs and the risks of cancer: More fakes than facts. (2019) (3)
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients (2017) (3)
Treating Hypertension with Angiotensin II Receptor Blockers (2005) (3)
Abstract 4377: Safety and Feasibility of Erythropoietin Administration in Patients with Acute ST-Elevation Myocardial Infarction (2008) (3)
Long-Term Care Quality Assurance Policies in the European Union (2012) (3)
PCSK9 inhibition: Not just LDL-Cholesterol knock down: A glimmer for cancer. (2021) (3)
Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients. (2019) (3)
Safety and efficacy of anti‐tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD (2019) (3)
Predictability of antihypertensive efficacy of selective β1 blockers (1983) (3)
Regulation of 11β -hydroxylase cytochrome P450 expression by cholesterol in spontaneously hypertensive rats (1995) (3)
Letter by Conti and Volpe regarding article, "Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium". (2007) (3)
Hypertension in Patients with Heart Failure with Reduced Ejection Fraction (2016) (3)
Impairment of atrial natriuretic factor response to acute saline load in hypertensives with family history of cardiovascular accidents. (1991) (3)
Calcium Channel Blockers for the Clinical Management of Hypertension (2018) (3)
May Measurement Month 2018: an analysis of blood pressure screening results from Italy (2020) (3)
The ‘ForLife’ Study (2003) (3)
Immigration Emergency in Italy: The Impact of Socioeconomic Status on Blood Pressure Levels and Control (2019) (3)
A Review of Angiotensin Receptor Blocker-based Therapies at all Levels of Cardiovascular Risk (2011) (3)
New therapies for arterial hypertension. (2016) (3)
New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies (2022) (3)
[Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension]. (2012) (3)
Changes in left ventricular anatomy and systemic hemodynamics induced by antihypertensive therapy with indenolol. (1987) (3)
World Hypertension Day 2021 in Italy: Results of a Nationwide Survey (2022) (2)
The lifespan determinant p66shc drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation (2013) (2)
Reduction of High Cholesterol Levels by a Preferably Fixed-Combination Strategy as the First Step in the Treatment of Hypertensive Patients with Hypercholesterolemia and High/Very High Cardiovascular Risk: A Consensus Document by the Italian Society of Hypertension (2022) (2)
A SPRINT towards tighter control of blood pressure in hypertension. (2021) (2)
The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk. (2021) (2)
Role of induced pluripotent stem cells in diagnostic cardiology (2021) (2)
Systolic blood pressure target less than 120 mmHg: the 'Chariot Allegory' in hypertension? (2020) (2)
Antihypertensive drugs and the risks of cancer: More fakes than facts. (2019) (2)
Abstract 18056: Activation of Nox4 Promotes Cardiomyocyte Autophagy and Survival During Nutrient Starvation (2012) (2)
Hyperbaric oxygen therapy in a case of cholesterol crystal embolization. (2011) (2)
High natriuretic peptide levels and low DBP: companion markers of cardiovascular risk? (2014) (2)
Metabolic Aspects and Associated Risk Factors VITAMIN D SUPPLEMENTATION AND INCIDENT PREECLAMPSIA : FINDINGS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED CLINICAL STUDIES (2019) (2)
NPPA/atrial natriuretic peptide is an extracellular modulator of autophagy in the heart (2022) (2)
Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy. (2003) (2)
Extemporaneous combination therapy with nebivolol/zofenopril in hypertensive patients: usage in Italy (2022) (2)
BNP level and post-transcatheter aortic valve replacement outcome: an intriguing J-shaped relationship. (2020) (2)
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring. (2018) (2)
Hyperglycemic Memory Bringing All the Strands Together (2013) (2)
The second life of the ambiguous angiotensin-converting enzyme 2 as a predictive biomarker for cardiometabolic diseases and death. (2020) (2)
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations (2022) (2)
Impact of physicians’ age on the clinical management of global cardiovascular risk: analysis of the results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation Educational Programme (2011) (2)
Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure. (2010) (2)
The cardiovascular benefits of statins outweigh adverse effects in primary prevention: results of a large systematic review and meta-analysis. (2021) (2)
Hypertension Management and Control in Italy: A Real-World Survey in Elderly Patients (2021) (2)
Cardiovascular Prevention: The Role of Second Generation of Nutraceuticals (2015) (2)
Role of angiotensin II AT1 and AT2 subtype receptors in the regulation of atrial natriuretic peptide expression in salt-restricted rats (2000) (2)
Restrictive cardiomyopathy and pseudoxanthoma elasticum skin lesions. (2016) (2)
Hemodynamic Mechanisms of the Blood Pressure Response to Atrial Natriuretic Factor in the Dog:.: Effects of Vagotomy (1986) (2)
[The HEAAL study]. (2010) (2)
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals. (2022) (2)
Renal denervation in the antihypertensive arsenal – knowns and known unknowns (2022) (2)
Influence of atrial natriuretic factor on forearm reflex vasoconstriction induced by cardiopulmonary or arterial receptor unloading. (1987) (2)
Hyperuricemia increases the risk of cardiovascular mortality associated with very high HdL-cholesterol level. (2022) (2)
Cerebrovascular Protection by New Antihyper tensive Drugs – Focus on RAS Blocking Agents in Stroke Prevention (2006) (2)
Genes and hypertension: stepping into the secret through the arterial wall. (2020) (2)
The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected ending. (2021) (2)
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis. (2016) (2)
RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure (2015) (2)
Haemodynamic and clinical effects of long-term treatment of essential hypertension with captopril. (1983) (2)
Red Blood Cell Distribution Width in Acute Coronary Syndromes (2013) (2)
Evaluation by multivariate analysis of changes in systolic time intervals during exercise in the supine and upright positions. (1980) (2)
Efficacy of Once-Daily Urapidil Treatment in Mild or Moderate Essential Hypertension Assessed by Ambulatory 24-Hour Blood Pressure Monitoring (2012) (2)
Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses. (1986) (2)
The reflex control of arginine-vasopressin release in essential hypertension. (1981) (2)
Risk stratifying asymptomatic left ventricular systolic dysfunction in the community: beyond left ventricular ejection fraction. (2019) (2)
Effect of furosemide on plasma concentration and beta-blockade by propranolol. (1979) (2)
3.12 Angiotensin II Receptor Blockers and Risk of Myocardial Infarction: a Meta-Analysis of Randomized Clinical Trials Updated Until May 1, 2008 (2008) (2)
Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values (2022) (2)
Therapeutic applications of angiotensin II receptor antagonists. (2000) (2)
Effect of complete cardiac denervation on atrial natriuretic factor release in baboons. (1992) (2)
TRANSCEND Aftermath (2009) (2)
Cardio-metabolic phenotype of HFpEF as a target of SGLT2i and GLP1-RA. (2020) (2)
CORONARY INTRASTENT RESTENOSIS AND BLOOD PRESSURE LEVELS: RETROSPECTIVE ANALYSIS OF A LARGE COHORT OF PATIENTS WITH CORONARY SINGLE VESSEL DISEASE: 1C.06 (2010) (2)
Real-life appraisal on blood pressure targets achievement in adult outpatients at high cardiovascular risk. (2020) (1)
Angiotensinogen and Angiotensins (2019) (1)
Reversal of left ventricular hypertrophy following treatment with beta-blockers: experience with tertatolol. (1986) (1)
P-329: Three chromosomal regions modulate an impaired endothelial dependent vasorelaxation in the stroke prone spontaneously hypertensive rat (2002) (1)
P117Cardiac magnetic resonance imaging to solve the diagnostic dilemma in two cases of MINOCA: different sides of the same coin (2019) (1)
Control of cardiovascular risk factors in recurrent Acute Coronary Syndrome (2017) (1)
A New Option for Therapeutic Management of Patients with Cerebrovascular Disease (2008) (1)
OR-26: The gene encoding atrial natriuretic peptide and the risk of ischemic stroke in males (2002) (1)
Similarities and Differences in Hypertension Guidelines (2005) (1)
(-)- and (±)-moprolol in the treatment of mild and moderate hypertension. A double-blind randomized trial (1984) (1)
Effect of direct renin inhibition on vascular function after long-term treatment with aliskiren in hypertensive and diabetic patients (2020) (1)
[A unique case of secondary takotsubo syndrome]. (2018) (1)
Cardiopulmonary exercise testing in heart failure: from ugly duckling to swan (2009) (1)
The "hidden side of the moon" in hypertension: When and why is dangerous low diastolic blood pressure? (2019) (1)
Lifestyle and cardiovascular disease: Barefooting through the guidelines. (2018) (1)
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (2022) (1)
Erythropoiesis‐stimulating agents in heart failure: leave it or re‐take it? (2015) (1)
[Mechanisms of regulation of arterial blood pressure: role of the sympathetic nervous system and of the renin-angiotensin system in patients on a low-sodium diet]. (1987) (1)
Abstract 12438: Vascular Hyperglycemic Memory is Abolished by in-vivo Silencing of the Mitochondrial Adaptor p66Shc (2011) (1)
Nifedipine inhibits superoxide production induced by pulsatile stretch in human aortic endothelial cells (2000) (1)
A Novel Molecule of the Angiotensin II Receptor Blocker Class (2005) (1)
265 Incidence, determinants and prognostic relevance of HS-troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients (2020) (1)
MAS RECEPTOR ACTIVATION CONTRIBUTES TO THE IMPROVEMENT OF VASCULAR REMODELLING INDUCED BY THE ANGIOTENSIN RECEPTOR BLOCKER OLMESARTAN IN SPONTANEOUSLY HYPERTENSIVE RATS: 5C.04 (2010) (1)
Blood pressure lowering drugs differ in their capacity to prevent type 2 diabetes. (2022) (1)
24Excess of myocardial water and fibrosis define myocardial hypertrophy in uremic but not in hypertrophic cardiomyopathy - TrueTypeCKD study (2019) (1)
An inflammatory ageing clock to detect cardiovascular and other age-related diseases: a new approach to preventive medicine. (2021) (1)
Letter by Assenza et al regarding article, "Electrocardiographic features of arrhythmogenic right ventricular dysplasia". (2010) (1)
Forearm Vascular Responsiveness tocal- and a2-Adrenoceptor Stimulation inPatients WithCongestive HeartFailure (1994) (1)
[The PARADIGM-HF study]. (2014) (1)
Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review (2020) (1)
Improving care for heart failure patients by COACHing clinicians to use decision-support tools. (2023) (1)
Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study (2023) (1)
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) (1)
Shooting beyond score: targeting organ disease to improve risk prediction in hypertension. (2012) (1)
Valsartan for prevention of recurrent atrial fibrillation (New England Journal of Medicine (2009) 360, (1606-1617)) (2009) (1)
Abstract 16655: Role of PKC{beta}II/p66Shc Pathway As A Determinant Of Metabolic Memory In Human Endothelial Cells (2010) (1)
A case of thrombolysis in acute pulmonary embolism with right atrial thrombus: comparing current and past guidelines (2009) (1)
The Role of Arterial Stiffness in Stratifying the Overall Cardiovascular Risk (2007) (1)
Are Post Hoc Analyses on Subgroups Sufficient to Support New Treatment Algorithms of Heart Failure? The Case of SGLT2 Inhibitors Associated with Sacubitril/Valsartan (2021) (1)
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury (2021) (1)
The role of atrial natriuretic factor in the control of circulatory homeostasis. (1990) (1)
Impact of a NDUFC2 Variant on the Occurrence of Acute Coronary Syndromes (2022) (1)
Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24 h ambulatory blood pressure monitoring database (2021) (1)
Aminoterminal natriuretic peptide as a determinant of PAI‐1 levels in a sample of the adult male Italian population (2011) (1)
Application of Hypertension Guidelines in Clinical Practice (2005) (1)
USE OF ALISKIREN IN THE CLINICAL PRACTICE: DATA FROM A LARGE ITALIAN COHORT OF HYPERTENSIVE PATIENTS INCLUDED IN THE NATIONAL AIFA WEB-BASED DRUG MONITORING SYSTEM: PP.LB3.442 (2011) (1)
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry (2022) (1)
Long-term management of Takotsubo syndrome: a not-so-benign condition. (2021) (1)
12.24 Coronary Intrastent Restenosis and Blood Pressure Levels: Retrospective Analysis of a Large Cohort of Patients with Coronary Single Vessel Disease (2008) (1)
Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants? (2020) (1)
Release of atrial natriuretic factor in hypertension (1989) (1)
MOLECULAR MECHANISMS UNDERLYING THE ANTIGROWTH PROPERTIES OF THE T2238C ATRIAL NATRIURETIC PEPTIDE MOLECULAR VARIANT IN HUMAN ENDOTHELIAL CELLS IN-VITRO: PP.21.342 (2010) (1)
Treatment of High-Risk Hypertensive Patients (2006) (1)
Follow-up, study design and outcome parameters. (2013) (1)
Chance for in-hospital pneumococcal vaccination. Analysis of discharge data from an Italian hospital (2016) (1)
Sacubitril/valsartan: potential impact of ARNi “beyond the Wall” of ACE2 on treatment and prognosis of heart failure patients with COVID-19 (2020) (1)
Microbiological ascertainment in patients with pneumonia: the experience of a teaching hospital in Rome. (2020) (1)
Hemodynamic Mechanisms of the Blood Pressure Response to Atrial Natriuretic Factor in the Dog: (1986) (1)
Abstract 45: Reduced Vascular Remodeling and Improved Endothelial Function in Transglutaminase 2 Knock-Out Mice Treated with Angiotensin II (2013) (1)
Adverse Effects of Statins (2005) (1)
Nationwide trends in hospitalization and surgical treatment of congenital and infantile cataract among italian children 4 years and younger. (2009) (1)
4.28 Conventional and Tissue Doppler Evaluation of Systolic and Diastolic Function in a Cohort of Paediatric Obese Subjects (2007) (1)
Myocardial Infarction in Patients Without Cardiovascular Risk Factors: Advanced Prediction Models to Unlock the Clinical Dilemma? (2022) (1)
Tailoring self-care education to heart failure patients through a narrative medicine approach using DNM, a web-based digital platform (2018) (1)
AT1R-AT2R Cross Talk (2015) (1)
Indomethacin blunts the late phase of nitroglycerin-induced coronary vasodilatation in dogs. (1985) (1)
[Cardiovascular risk in arterial hypertension: role of family history]. (1994) (1)
Incidence of sudden death among patients with premature ventricular contractions: An epidemiological study. (1979) (1)
Could maternal ethnicity be a determinant of healthcare costs for birth assistance? Insights from a retrospective hospital-based study for the implementation of a woman-centered approach in obstetrics (2020) (1)
Acetyltransferase gene non-derepressible 5 mediates hyperglycemia-induced endothelial oxidative stressin patients with type 2 diabetes (2013) (1)
Aspirin in primary prevention: 'nothing else matters' … like hypertension. (2019) (1)
1431Modulation of JunD by miR-494-3p causes intra-myocardial lipid accumulation and obesity cardiomyopathy: a study in mice and humans (2018) (1)
Insulin resistance and hypertension: the link (2007) (1)
Deletion of the AP-1 Transcription Factor JunD Induces Oxidative Stress and Accelerates Age-Related Endothelial Dysfunction (2013) (1)
Synergistic effects of cardiac resynchronization therapy and drug up-titration in heart failure: is this enough? (2015) (1)
Release of prostaglandin‐like material by depressor stimulation in rabbits * (1978) (1)
Exploring RNA biomarkers in patients with acute myocarditis. (2021) (1)
Vessels and Endothelium (2008) (1)
Genetic Factors Underlying Impaired Endothelium-Dependent Vasorelaxation in the Stroke-Prone Spontaneously Hypertensive Rat (2003) (1)
ACUTE MYOCARDITIS FOLLOWING COVID-19 VACCINATION: A PECULIAR CASE SERIES (2022) (1)
Mapping genes for stroke: Genetic dissection of a rat model of complex human disease (1997) (1)
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients (2021) (1)
Long-term effects of felodipine in patients with mild heart failure treated chronically with enalapril: A randomized, placebo-controlled study (1998) (1)
Electrocardiographic changes in focal takotsubo syndrome: a case report. (2019) (1)
Repurposing Cardio-Metabolic Drugs to Fight Covid19 (2021) (1)
Prognostic implications of nonsustained ventricular tachycardia morphology in high‐risk patients with hypertrophic cardiomyopathy (2020) (1)
Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension (2015) (1)
Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials (2021) (1)
The Age of Nutraceuticals: Exploring New Therapeutic Targets (2016) (1)
[Neurohormone hypothesis in heart failure: new therapeutic opportunities]. (1999) (1)
[The effects of the stellate ganglion electrostimulation on the coronary circulation of the dog (author's transl)]. (1980) (1)
Coronary artery fistula from the circumflex artery to the left atrium: invasive and non-invasive imaging techniques. (2008) (1)
Targeting Cyclic Guanylate Monophosphate in Resistant Hypertension and Heart Failure: Are Sacubitril/Valsartan and Vericiguat Synergistic and Effective in Both Conditions? (2021) (1)
Unhealthy lifestyles mediate only a small proportion of the socioeconomic inequalities' impact on cardiovascular outcomes in US and UK adults: a call for action for social cardiology. (2021) (1)
Patient at intermediate cardiovascular risk: statins, yes! - antihypertensive therapy, maybe. (2018) (1)
Vascular Senescence at the Crossroad between Oxidative Stress and Nitric Oxide Pathways (2008) (1)
Effects of lower body negative pressure in hypertensive patients with left ventricular hypertrophy. (1986) (1)
Use of predictive markers to improve cardiovascular protection. (2007) (1)
Angiotensin receptor blockers: Clinical relevance and new opportunities (2012) (1)
Modern cardiovascular risk management in clinical practice (2009) (1)
Cryoblation as first-line treatment of new-onset atrial fibrillation? (2021) (1)
9.9 Role of the Different Components of Metabolic Syndrome in the Pathogenesis of Adrenergic Overdrive (2008) (1)
Renal protection with telmisartan: a key target when managing hypertension and diabetes (2007) (1)
Angiotensin Receptor Blockers (2012) (1)
Impact of the direct angiotensin II type 2 receptor stimulation on renal function toward a sex-specific therapeutic approach for hypertension. (2014) (1)
[Diffusion of clinical governance among the Italian Local Health Units (LHUs). Analysis of the Health Surveys, the Firm Acts and the Health Plans]. (2009) (1)
Prolyl-isomerase-1 (pin1) mediates hyperglycemia-induced oxidative stress, endothelial function and vascular inflammation: insights in patients with type 2 diabetes (2013) (1)
Iron heart. (2021) (1)
Abstract P3005: P66shc Plays a Role in Aldosterone Induced Vascular Remodeling and Dysfunction (2019) (0)
Invasive treatment strategy in elderly patients with non ST elevation acute coronary syndromes. A sensitivity analysis of a large monocentric retrospective study (2013) (0)
THE RENIN INHIBITOR ALISKIREN IMPROVES VASCULAR REMODELING IN DOUBLE TRANSGENIC RATS: 5D.09 (2011) (0)
Vulnerable non-culprit coronary plaques: are they worth treating? (2021) (0)
Epigenetics in Cardiac Health and Disease (2016) (0)
7.17 M24-Hour Ambulatory Blood Pressure Monitoring in a Cohort of Paediatric Obese Subjects: Diagnostic Option and Clinical Feasibility (2007) (0)
4.29 Impact of Different Remodeling Patterns of the Left Ventricle on Indexes of Systolic Performance and Function in Hypertensive Patients with Preserved Ejection Fraction (2007) (0)
In Memoriam: professor Antonio Salvetti (1936-2021). (2021) (0)
EFFECTS OF GUANETHIDINE ON HISTAMINE RELEASE DURING REFLEX VASODILATATION IN THE DOG (1977) (0)
The Effect of the Menopause on Women at Risk of Heart Disease (1999) (0)
Overview of mitral valve replacement versus mitral valve repair due to ischemic papillary muscle rupture: A meta-analysis inspired by a case report (2022) (0)
Radial Approach versus Femoral Approach with Vascular Closure Devices : Systematic Review and Meta-analysis (2015) (0)
History of Cardiovascular Accidents (2005) (0)
Investigation of the effects induced on endothelial function by the human T2238C ANP gene molecular variant (2011) (0)
[Study of the mechanisms of impaired beta-receptor responsiveness in arterial hypertension]. (1983) (0)
[Prospects of pharmacologic treatment of post-ischemic heart failure]. (1995) (0)
[PP.06.08] PREVALENCE AND CLINICAL OUTCOMES OF WHITE COAT AND MASKED HYPERTENSION COMPARED TO NORMOTENSION AND SUSTAINED HYPERTENSION. (2017) (0)
Abstract 16477: Targeting Prolyl-isomerase-1 Protects Against Hyperglycemia-induced Endothelial Dysfunction and Vascular Inflammation: Alterations in Patients With Type 2 Diabetes (2013) (0)
Use of Fixed-Dose Combinations in Hypertension and Cardiovascular Disease Prevention (2018) (0)
Atherosclerosis and Inflammation (2008) (0)
Heart Failure Progression in Hypertrophic Cardiomyopathy (2016) (0)
[Effects of saline load on the response to isoproterenol in normal and hypertensive subjects]. (1982) (0)
[The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure]. (1991) (0)
Correction to: Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention (2022) (0)
ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY: HT.1.03 (2010) (0)
PP.27.11: STRUCTURAL AND FUNCTIONAL ALTERATIONS IN CEREBRAL AND MESENTERIC SMALL RESISTANCE ARTERIES FROM CONGENIC LINES FOR A MAJOR STROKE QTL ON RAT CHROMOSOME 1 AFTER HIGH SALT DIET (2015) (0)
7.18 Metabolic Profile in a Large Cohort of Hypertensive Patients (2007) (0)
Inﬂuence of rs5065 Atrial Natriuretic Peptide Gene Variant on Coronary Artery Disease (2012) (0)
MANAGEMENT OF BLOOD PRESSURE CONTROL: AT THE CUTTING EDGE (2016) (0)
Strategies to improve control of blood pressure in hypertension: moving towards a 70% objective (2013) (0)
Involvement of Health Professionals: From the General Practitioner to the Hypertension Specialist and the Hypertension Center (2013) (0)
Beta-blocking agents in cardiology. Metoprolol (1979) (0)
The UrgeRe (Urgenze Ipertensive: Un Progetto Educazionale Fondato Sulla Vita Reale, Hypertensive Urgencies: A Project in the Real World) Project (2021) (0)
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension (2009) (0)
Metabolic Aspects and Mechanisms (2008) (0)
[Preliminary study of the release of prostaglandins during vasodilation induced by depressor nerve stimulation in the rabbit]. (1977) (0)
Mechanisms underlying systemic hemodynamic responses to experimental coronary artery occlusion. A preliminary study with hexamethonium. (1981) (0)
Hypertension Surveys (2004) (0)
RENAL DAMAGE IN HYPERTENSIVE WOMEN IN ITALY: PREVALENCE AND ASSOCIATED CARDIOVASCULAR RISK FACTORS.THE I-DEMAND STUDY: PP.14.386 (2011) (0)
Beneficial Effects of Citrus Bergamia Polyphenolic Fraction on Saline Load-Induced Injury in Primary Cerebral Endothelial Cells from the Stroke-Prone Spontaneously Hypertensive Rat Model (2023) (0)
[Preliminary study of the cardiovascular effect of neostigmine in "borderline" arterial hypertension]. (1980) (0)
Genetic analysis of the endothelial-dependent impaired vasorelaxation in the stroke-prone spontaneously hypertensive rat: a candidate gene approach. (1999) (0)
4.14 Impact of Gender on Left Ventricular Adaption to Chronic Pressure Overload in Hypertensive Adults with Preserved Ejection Fraction (2007) (0)
Regulation of 11$beta;-hydroxylase biosynthesis by high cholesterol intake in spontaneously hypertensive rats (SHR). (1995) (0)
Cardiovascular risk and the COVID-19 pandemic: a retrospective observational study in a population of healthcare professionals (2023) (0)
Uncoupling protein 2 and renal damage in SHRsp (2014) (0)
Co-morbidity (HFrEF and HFpEF): hypertension (2018) (0)
Abstract 2383: Baseline Atrial Natriuretic Peptide is the Best Predictor of Long-Term Survival in Chronic Heart Failure: a 15-Year Prospective Follow-Up Study (2007) (0)
EFFECTS OF BARIATRIC SURGERY ON INSULIN SENSITIVITY AND SYMPATHETIC NERVE TRAFFIC IN OBESE SUBJECTS. A LONGITUDINAL STUDY: 1D.04 (2011) (0)
Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination (2022) (0)
A New ECG Marker of Sudden Death in Brugada Syndrome: the S wave in lead I (0)
Transient enhancement ofsympathetic nervous systemactivity bylong-term restriction ofsodium (1985) (0)
Renal hemodynamic effects of atrial natriuretic factor (1985) (0)
SERUM URIC ACID, LEFT VENTRICULAR MASS AND CARDIOVASCULAR DEATH. THE URIC ACID RIGHT FOR HEART HEALTH (URRAH) STUDY (2022) (0)
What's HIV got to do with cardiovascular disease? (2018) (0)
SESSION 1 - Atherosclerosis, Inflammation and Plaque Vulnerability (2016) (0)
Left Ventricular Hypertrophy and Microalbuminuria in Hypertensive Patients With and Without Metabolic Syndrome: 6.15 (2005) (0)
Directly Stimulates Release of Atrial Natriuretic Factor in Isolated Rabbit Hearts (2005) (0)
Abnormalities of endothelium-dependent vasorelaxation in the stroke-prone phenotype of intercross SHRSP/SHR Rats (1995) (0)
How to Improve Patients' Adherence to Antihypertensive Therapy: A Simple Solution for a Big Trouble. (2018) (0)
Journal Pre-proof LDL-cholesterol control in the primary prevention of cardiovascular diseases: An Expert Opinion for clinicians and health professionals (2022) (0)
Natural Disaccharide Reduces Cardiac Remodeling After Myocardial Infarction through Autophagy Activation (2019) (0)
[Mutations and polymorphisms: clinical significance in cardiology]. (1999) (0)
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation (2012) (0)
Abstracts from 2020 national congress of the Italian Society of Hypertension (SIIA) (2020) (0)
8.1 Depression and Cardiovascular Risk in Older Subjects: Role of Blood Pressure Variability (2007) (0)
Hot topics in hypertension: Foreword (2009) (0)
WHEN THE GOING GETS TOUGH , THE TOUGH GET GOING This satellite symposium took place on 13 th June 2015 as part of the 25 th European Meeting on Hypertension and Cardiovascular Protection in Milan , Italy Chairperson (2015) (0)
Adrenergic and metabolic effects of bariatric surgey in obese subjects: a longitudinal study (2011) (0)
[PP.09.15] CHRONIC HEMODIALYSIS CONTRIBUTES TO INCREASED ARTERIAL STIFFNESS AND TO IMPAIRED DIASTOLIC FUNCTION IN PATIENTS WITH END-STAGE RENAL DISEASE AFTER SIXTY MONTHS OF TREATMENT (2017) (0)
Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology (2022) (0)
Reprogramming Epigenetic Changes Blunts p66Shc-induced Vascular Dysfunction In Experimental and Human Obesity: Insights for Mechanisms-Based Therapeutic Strategies (2013) (0)
Defective suppression of aldosterone biosynthesis during stroke permissive diet in the stroke-prone SHR (1999) (0)
Abstract 15689: Activation of PKR-Like Endoplasmic Reticulum Kinase is Required for Autophagy Stimulation and Cardiomyocyte Survival During Acute Myocardial Ischemia (2014) (0)
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice]. (2022) (0)
[PP.06.09] POTENTIAL IMPACT OF STATIN USE ON DAY-TIME AND NIGHT-TIME BLOOD PRESSURE LEVELS: A RETROSPECTIVE ANALYSIS OF A LARGE DATABASE OF 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING (2017) (0)
Hypertension and metabolic syndrome: Association between an inflammatory pattern and target organ damage (2006) (0)
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial (2011) (0)
ssociation of Atrial Natriuretic eptide and Type A Natriuretic Peptide eceptor Gene Polymorphisms With Left entricular Mass in Human Essential Hypertension (2006) (0)
Abstract P160: Role of Uncoupling Protein 2 in Stroke Susceptibility of Stroke-prone Spontaneously Hypertensive Rat (2015) (0)
IS PREGNANCY ASSOCIATED WITH ADVERSE RIGHT VENTRICULAR REMODELING IN WOMEN WITH REPAIRED TETRALOGY OF FALLOT (2012) (0)
PROGNOSTIC CUT-OFF VALUES OF SERUM URIC ACID ASSOCIATED WITH FATAL AND NON FATAL INCIDENT MYOCARDIAL INFARCTION INDEPENDENTLY OF ARTERIAL HYPERTENSION IN A LARGE COHORT (2019) (0)
[New antithrombotic drugs in cardiovascular disease]. (2006) (0)
24-hour blood pressure monitoring : its efficacy and techniques (2011) (0)
The effects of atrial natriureticpeptide on left ventricular function in subjects with heart failure].Cardiologia. 1991 May;36(5):351-6. Italian. PubMed PMID: 1836751. (1991) (0)
Animal Cytogenetics and Comparative Mapping (2002) (0)
Long QTc in hypertrophic cardiomyopathy: A consequence of structural myocardial damage or a distinct genetic disease? (2023) (0)
Glucocorticoids in patients with immune-mediated inflammatory diseases: a neglected cardiovascular risk factor. (2021) (0)
[Aspirin use for the primary prevention of cardiovascular disease and cancer: reflections on the 2016 U.S. Preventive Services Task Force recommendation statement]. (2016) (0)
Evolving Pathophysiological Perspectives in Endothelial Dysfunction (2004) (0)
4.23 Assessment of Right Ventricle Systolic and Diastolic Function in Hypertensive Patients with and without Metabolic Syndrome (2007) (0)
National Cross-Sectional Survey on Blood Pressure: A Gateway to a Better Appraisal of Hypertension in the Young (2016) (0)
How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion. (2023) (0)
Weekly Journal Scan Cryoblation as first-line treatment of new-onset atrial fibrillation? (2021) (0)
β-Blockers and Diuretics in the Treatment of Hypertension (2008) (0)
[PP.04.30] PRESERVED CARDIOVASCULAR PERFORMANCE AND OPTIMAL HEART RATE CONTROL IN PATIENTS WITH POST-ISCHEMIC LEFT VENTRICULAR DYSFUNCTION TREATED WITH IVABRADINE FOR ONE YEAR (2017) (0)
Abstract 13776: QRS Duration and Epsilon Wave on Surface Electrocardiogram Are Markers of Disease Severity in Patients With Ebstein Anomaly (2010) (0)
Abstract P275: Transglutaminase-2 Contributes to Angiotensin II-Induced Reactive Oxygen Species Production in Mice (2018) (0)
New options for therapeutic management of patients with cardiovascular disease. A closer look at clinical trials with telmisartan (2009) (0)
The Prevention of Vascular Injury in a Genetic Model of Hypertension (1995) (0)
Genetic Variant-Adrenergic Receptor Polymorphism Potentiates Platelet Reactivity in Patients With 2 (2014) (0)
Role of the renin-angiotensin system in hypertension (2007) (0)
Hyperglycemia selectively increases the expression of cycloxygenase-2 in human aortic endothelial cells (2000) (0)
Erratum: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities [High Blood Press Cardiovasc Prev, (2014), 21, (29-36), DOI 10.1007/s40292-013-0034-z] (2015) (0)
NEW ONSET ATRIAL FIBRILLATION IN RANDOMISED CLINICAL TRIALS PERFORMED WITH ANGIOTENSIN-CONVERTING ENZIME INHIBITORS OR ANGIOTENSIN II RECEPTOR BLOCKERS: AN UPDATED META-ANALYSIS.: PP.27.81 (2010) (0)
AMINO TERMINAL NATRIURETIC PEPTIDES AND ASSOCIATION TO GLOBAL CARDIOVASCULAR RISK IN A MALE ADULT POPULATION FROM SOUTHERN ITALY: 2B.08 (2011) (0)
The Multicentre Atorvastatin Plaque Stabilisation (MAPS) Study (2003) (0)
Metabolic syndrome is an independent predictor of systolic myocardial function assessed by Tissue Doppler Imaging in hypertensive patients with preserved ejection fraction (2006) (0)
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide (2022) (0)
[The early hemodynamic and hormonal changes in patients with left ventricular dysfunction]. (1991) (0)
Long term comparative study of guanfacine and alpha-methyldopa in essential hypertension. (1980) (0)
Mechanisms of blood pressure homeostasis: relationships between the parasympathetic system and the atrial natriuretic factor (1987) (0)
Impaired ability to increase circulating atrial natriuretic factor (ANF) in patients with mild left ventricular dysfunction (1991) (0)
Anemia and heart failure: Is there still a role for erythropoiesis-stimulating agents? (2017) (0)
MELD-XI SCORE AND FONTAN FAILURE IN PATIENTS WITH SINGLE VENTRICLE PALLIATION FOR COMPLEX CONGENITAL HEART DISEASE (2011) (0)
The Burden of Heart Failure: Physicians’, Patients’, and Caregivers’ Perspectives Using Narrative Medicine (2020) (0)
attenuation of the circulatory consequences of acute volume expansion Hemodynamic responses to atrial natriuretic factor in nephrectomized rabbits (2011) (0)
Cardiopulmonary receptors and coronary circulation. (1990) (0)
One-shot thrombolysis for the management of acute ischaemic stroke. (2022) (0)
Abstract 16325: WW45, a Scaffold Protein, is a Positive Regulator of Mst1 and Stimulates Myocardial Injury Through the Suppression of YAP (2013) (0)
Highlights from International Congress (2008) (0)
ANGIOTENSIN II-INDUCED TRANSGLUTAMINASE 2 REGULATES P-38 MAP-KINASE LONG TERM EXPRESSION IN SHR VASCULAR SMOOTH MUSCLE CELLS: 2C.02 (2010) (0)
Treatment of Hypertension (2003) (0)
Current applications and limitations of European guidelines on blood pressure measurement: implications for clinical practice (2022) (0)
Pathophysiological Mechanisms and Prognostic Significance of Renal Functional Impairment in Cardiac Patients (2010) (0)
Plasmatic and phenotypic effects with alirocumab, a PCSK9 inhibitor, in familial hypercholesterolemia treatment (FH). (2017) (0)
Why a New Hypertension Journal? (2003) (0)
10.1 Sympathetic Responses to Ventricular Extrasystolic Beats in Obese Subjects without and with Sleep Apnoea (2008) (0)
DETERMINANTS OF N-TERMINAL PRO ATRIAL NATRIURETIC PEPTIDE PLASMA LEVELS IN A SURVEY OF ADULT MALE POPULATION FROM SOUTHERN ITALY: PP.12.450 (2010) (0)
A molecular variant of the at1r gene is a risk factor for ischemic stroke in hypertensive subjects (2004) (0)
Cerebrovascular prevention by angiotensin II receptor antagonists (2006) (0)
941 Left ventricular mass and left ventricular function indexes in obese hypertensive patients (2005) (0)
[Appropriateness criteria for the treatment of atrial fibrillation with dronedarone: practical issues. An Italian cardiologists' expert opinion]. (2013) (0)
Haemodynamic effects of atrial natriuretic factor in the hypertensive patient (1987) (0)
EFFECTS OF ATORVASTATIN AND ROSUVASTATIN ON RENAL FUNCTION IN PATIENTS AT HIGH CARDIOVASCULAR RISK : A META-ANALYSIS OF 23 RANDOMIZED TRIALS (2012) (0)
Abstract 16519: Epigenetic Remodeling of Nox2 by Acetyltransferase Gcn5 Drives Hyperglycemia-Induced Endothelial Oxidative Stress (2013) (0)
Elevated cardiac troponins are predictive factors for cardiovascular events hemodilaysis patients without myocardial infarction (2005) (0)
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum] (2017) (0)
The Growing Importance of Socioeconomic Aspects in Cardiovascular Disease (2007) (0)
Antihvwrtensive Treatment with Trandolawil (1992) (0)
From the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide? (2022) (0)
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP (2017) (0)
Abstract 1672: Persistence of Endothelial Dysfunction as a Marker of Metabolic Memory in Diabetic Mice after Glucose Normalization (2008) (0)
Presenilin Mediated Ca2+ Changes and Protein Quality Control in Heart Failure (2011) (0)
REPORTS ON HYPERTENSION Hemodynamic and Hormonal Effects of Atrial Natriuretic Factor in Patients With Essential Hypertension (2010) (0)
What Should We Expect from the Next Guidelines on Hypertension? (2005) (0)
Angiotensin receptor blockers and myocardial infarction : the importance of dosage. Authors' reply (2006) (0)
NEW ONSET DIABETES MELLITUS IN RANDOMISED CLINICAL TRIALS PERFORMED WITH ACE INHIBITORS OR ANGIOTENSIN II RECEPTOR BLOCKERS: AN UPDATED META-ANALYSIS VERSUS PLACEBO: PP.27.88 (2010) (0)
mTORC 2 Regulates Cardia c Response to Stress by Inhibiting MST 1 Graphical Abstract Highlights (2015) (0)
heart failure responses to volume overload in patients with dilated cardiomyopathy and mild Angiotensin converting enzyme inhibition restores cardiac and hormonal (2011) (0)
Angiotensin Converting EnzymeInhibition Restores Cardiac andHormonalResponses to VolumeOverload inPatients WithDilated Cardiomyopathy andMildHeartFailure (1992) (0)
Relation of delayed Intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy. (2022) (0)
Lo studio Paradigm-HF (2014) (0)
[Residual risk in cardiovascular prevention]. (2008) (0)
[Optimal therapeutic management in the clinical journey of patients with heart failure]. (2020) (0)
[Interrelation between the autonomic nervous system and the baroreceptors in hypertension]. (1981) (0)
EFFICACY AND TOLERABILITY OF TRIPLE COMBINATION THERAPY (TCT) WITH OLMESARTAN MEDOXOMIL (O) PLUS AMLODIPINE (A) PLUS HYDROCHLOROTHIAZIDE (H) COMPARED WITH DUAL COMBINATION THERAPY (DCT) WITH O PLUS A: 4A.04 (2011) (0)
[Structure and biological action of the atrial natriuretic factor (auriculin)]. (1986) (0)
MICROVASCULAR ANGINA IS ASSOCIATED WITH SYSTEMIC DYSFUNCTION OF PERIPHERAL RESISTANCE ARTERIES (2021) (0)
VHRM_A_337640 507..515 (2022) (0)
Excess of dyslipidemia in low income countries: The case of Colombia in the PURE study. (2019) (0)
TRANSGLUTAMINASE-2 CONTRIBUTES TO REACTIVE OXYGEN SPECIES PRODUCTION IN MICE INFUSED WITH ANGIOTENSIN-II (2018) (0)
Related articles (2013) (0)
10.13 Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients (2007) (0)
Eplerenone works. Does it matter how? (2012) (0)
The prognostic role of the echocardiographic tricuspid annular plane systolic excursion/systolic pulmonary arterial pressure (TAPSE/sPAP) ratio and its relationship with NT-proANP plasma level in systemic sclerosis (2023) (0)
ROLE OF ALDOSTERONE AND P66SHC PROTEIN ON EXPRESSION OF THE SODIUM-GLUCOSE TRANSPORTER SGLT2 IN THE VASCULAR SYSTEM (2021) (0)
Decline in blood pressure control trends in the US: a real step back: Comment on National Health and Nutrition Examination Survey (NHANES) data. (2020) (0)
A9 - Impaired natriuretic and ANP responses to high salt intake in patients with left ventricular dysfunction (1995) (0)
Recurrent infective endocarditis in a drug addict (2018) (0)
Abstract 2392: Arterial Stiffness as an Independent Predictor of Longitudinal Changes in Cognitive Function in the Elderly (2006) (0)
High Blood Pressure & Cardiovascular Prevention is now on MEDLINE (2011) (0)
[Valsalva's maneuver in the evaluation of baroreceptor sensitivity in borderline hypertensives: comparative study with other methods]. (1982) (0)
Potassium canrenoate and chlorthalidone in the treatment of mild or moderate essential hypertension (1984) (0)
heart failure Tumor necrosis factor-alpha as trigger of platelet activation in patients with (2013) (0)
Gender differences in acute coronary syndromes: Do they count? (2017) (0)
The Myth of Janus (2009) (0)
Abstract 16527: Epigenetic Signatures of p66Shc Promoter Contribute to Persistent Endothelial Dysfunction in Type 2 Diabetics With Optimal Glycemic Control (2013) (0)
[Role of histamine in the regulation of peripheral vascular tension in the dog]. (1978) (0)
[Preliminary study of the combined administration of furosemide and propranolol. Evaluation of serum propranolol]. (1978) (0)
Benefits of angiotensin-II receptor blockers. Are we going beyond blood pressure control? (2006) (0)
Abstract 16883: Role of MAS Receptor Activation on Vascular Remodelling in Presence of Angiotensin II Receptor Blockade in Spontaneously Hypertensive Rats (2010) (0)
Abstract 024: The Direct Renin Inhibitor Aliskiren Improves Vasodilation and Endothelial Function in Resistance Arteries from Diabetic and Hypertensive Patients (2015) (0)
Hypertension and Cardiovascular Risk: The Importance of a Global Approach to Risk Management in the Light of Current Hypertension Guidelines (2008) (0)
[Valsalva's maneuver in the evaluation of the baroceptor sensitivity in borderline hypertensives: comparative study of other methods]. (1982) (0)
Splenic doppler sonography and echocardiography are useful in monitoring right heart failure (2004) (0)
9.1 Pro-Arrhythmogenic Role of Sympathetic Activation and Baroreflex Dysfunction in Human Obesity (2008) (0)
How much drug-induced blood pressure reduction is effective and safe in heart failure? (2019) (0)
Network meta-analysis of heart failure prevention by antihypertensive drugs - Reply (2011) (0)
[PP.01.17] ADDING HYPERTENSION-RELATED MARKERS OF ORGAN DAMAGE TO RISK SCORE MODELS IMPROVES CARDIOVASCULAR RISK ASSESSMENT: RETROSPECTIVE ANALYSIS OF A LARGE COHORT OF ADULT OUTPATIENTS (2017) (0)
RECIPROCAL CONGENIC LINES FOR A MAJOR RECIPROCAL CONGENIC LINES FOR A MAJOR RECIPROCAL CONGENIC LINES FOR A MAJOR RECIPROCAL CONGENIC LINES FOR A MAJOR (2006) (0)
baroreflex responses in humans Converting enzyme inhibition prevents the effects of atrial natriuretic factor on (2011) (0)
Abstract 406: Improved Angiotensin II Type 2 Receptor Expression and Function in Transglutaminase 2 Knock-Out Mice Treated with Angiotensin II (2013) (0)
Omega-3 in Antiarrhythmic Therapy (2012) (0)
Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell (1999) (0)
Out-of-Hospital Cardiac Arrest: Handle With Care-Comment on the Resuscitation Outcomes Consortium Cardiac Epidemiologic Registry. (2020) (0)
Renin-angiotensin system blockers increase risk of angio-oedema (2013) (0)
Effort angina in a patient with advanced coronary artery disease. Role played by coronary angiography, Ivus and cardiac CT: case report (2008) (0)
Hyperglycemia-induced myocardial oxidative stress and inflammation persist despite optimal glycemic control: role of mitochondrial adaptor p66shc (2013) (0)
Efficacy of zofenopril or irbesartan both combined with hydrochlorothiazide in elderly subjects with isolated systolic hypertension untreated or uncontrolled by monotherapy (2014) (0)
C-reactive protein, metabolic syndrome and target organ damage in the hypertensive patient: three steps on the same way? (2005) (0)
Predictability of antihypertensive efficacy of selective beta 1 blockers. (1983) (0)
Abnormal Hormonal andRenalResponses to Saline LoadinHypertensive Patients With Parental History ofCardiovascular Accidents (1991) (0)
Abstract 16955: The Direct Renin Inhibitor Aliskiren Improves Vascular Remodeling in Transgenic Rats Harboring Human Renin and Angiotensinogen Genes (2011) (0)
W16-P-026 Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in CHD patients with hypercholesterolemia (2005) (0)
P66SHC KNOCK-OUT PREVENTS ALDOSTERONE INDUCED VASCULAR REMODELING AND DYSFUNCTION (2019) (0)
EMERGING ANTIHYPERTENSIVE DRUGS (2014) (0)
P-218 MP-5: Role of ANP gene on cardiac hypertrophy in essential hypertension (2005) (0)
ALTERATIONS OF RETINAL MICROVASCULAR NETWORK IN THE HIGH-NORMAL BLOOD PRESSURE STATE: EVIDENCE AND MECHANISMS: PP.35.449 (2010) (0)
[Role of histamine in the genesis of hypoxic pulmonary vasoconstriction: study with disodium cromoglycate]. (1978) (0)
[Hormonal control of the endocrine function of the heart]. (1990) (0)
Reducing therapeutic inertia to improve blood pressure control: the Spanish lesson. (2014) (0)
TCT-421 Radial Approach versus Femoral Approach with Vascular Closure Devices: Systematic Review and Meta-analysis (2015) (0)
Optimal Antihypertensive Combination Treatments (2012) (0)
Head-to-Head Intervention Trials in Hypertension (2005) (0)
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials]. (2022) (0)
Abstract 17515: Randomized, Double-blind, Placebo-controlled, Assessment of the Efficacy and Safety of Dietary Supplements in Pre-hypertension - the Pre-hypertension Treament With a Combination of Dietary Supplements and Life-style Modifications (PYRAMIDS) Trial (2014) (0)
PROGNOSTIC CUTOFF OF TRIGLYCERIDES PREDICTING CARDIOVASCULAR OUTCOME IN A LARGE REGIONAL-BASED ITALIAN DATABASE (2022) (0)
Recurrence of acute coronary syndrome during inadeguate control of cardiovascular risk factors. (2017) (0)
Subject Index, Vol. 6 (Suppl. 2), 1986 (1986) (0)
[Echocardiographic evaluation of the long-term treatment of arterial hypertension with metoprolol]. (1980) (0)
Main Studies That Investigated the Role of mTOR Kinase in the Regulation of Cardiac Physiology and Response to Stress In Vivo Cardiac Condition Study Type of mTOR Modulation and Animal Model Effect on the Heart Development / physiological conditions (2014) (0)
Dyslipidaemia in Hypertension (2019) (0)
[Clinical trial of a new antihypertensive preparation: guanfacine]. (1979) (0)
Synthetic ANF Potentiates Bradycardic Baroreflex Response in the Rabbit (1986) (0)
Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC) (2023) (0)
Flu Vaccination as a Key Prevention Recommendation for Patients at High Cardiovascular Risk: The Next Season’s Scenario (2022) (0)
Toward a Sex-Specific Therapeutic Approach for Hypertension Impact of the Direct Angiotensin II Type 2 Receptor Stimulation on Renal Function: (2014) (0)
Electrocardiographic features and clinical course of patients with hypertrophic cardiomyopathy and left ventricular apical aneurysm (2013) (0)
Abstract 16552: Cardiac Deletion of WW45 Abrogates the Deleterious Effects of Mst1 Activation During Ischemia/Reperfusion Through YAP Activation (2012) (0)
Fixed-dose combination therapy to overcome unmet needs in hypertension: Focus on olmesartan medoxomil/amlodipine (2009) (0)
Scientific Contributions Insulin Blunts Sympathetic Vasoconstriction Through the e * 2-Adrenergic Pathway in Humans (2005) (0)
[Effects of metoprolol on myocardial performance in hypertensive patients during exercise (author's transl)]. (1980) (0)
Behaviour of regional sympathetic nerve traffic in obstructive sleep apnea syndrome (2011) (0)
[OP.3C.01] COMPARISON BETWEEN EUROPEAN SYSTEMATIC CORONARY RISK EVALUATION AND ITALIAN CUORE ALGORITHMS IN ADULT OUTPATIENTS FOLLOWED BY GENERAL PRACTITIONERS AND SPECIALISED CENTRES (2017) (0)
[Effects of long-term treatment with various antihypertensive drugs on the cardiac mass and on the hemodynamics of patients with essential arterial hypertension]. (1983) (0)
Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions (2019) (0)
A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment (2021) (0)
Differences in cardiovascular risk factors between men and women in the Acute Coronary Syndromes (2017) (0)
Abstract MP10: Early Functional and Structural Alterations of Resistance Arteries in Mice Treated with an Inhibitor of the Vascular Endothelial Growth Factor Receptor (2014) (0)
Recurrent Infective Endocarditis in a Drug Addict: A Case Report (2018) (0)
[The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension]. (1997) (0)
BEHAVIOUR OF REGIONAL SYMPATHETIC DRIVE IN OBSTRUCTIVE SLEEP APNEA SYNDROME: 2D.04 (2011) (0)
Abstract 16705: Nox4-Derived ROS Production in the Endoplasmic Reticulum Promotes Autophagy During Cardiomyocyte Nutrient Deprivation Through the PHD4/ PERK Pathway (2013) (0)
Glycaemicindex: an emergent global silent killer for the heart. (2021) (0)
504 Comparison of cardiovascular risk scores to predict anthracycline-induced cardiotoxicity in early breast cancer patients (2021) (0)
Absence of the “Yin/Yang effect” for AT1 and AT2 angiotensin II subtype receptors in the modulation of salt-regulating hormone secretion in the rat (1998) (0)
Abstract 16610: High Fat Diet-induced Obesity Is Associated With Increased Ischemia Susceptibility Due To Deregulated Activation Of The Rheb/mTORC1 Pathway And Inhibition Of Autophagy (2011) (0)
[Effects of atrial natriuretic peptide on left ventricular function in man]. (1989) (0)
D101 Effect of felodipine on progression of ventricular dysfunction and symptoms in patients with ischemic mild heart failure chronically treated with enalapril (1997) (0)
2.23 Development of Heart Failure in Hypertension: Analysis of Recent Clinical Trials (2007) (0)
Selected Abstracts from XXXVI National Congress of the Italian Society of Hypertension (SIIA), Rome, 26–28 September 2019 (2019) (0)
EPIGENETIC EFFECT OF DIABETES ON CODING AND NON-CODING PLATELET TRANSCRIPTOME IN ACUTE CORONARY SYNDROME (2019) (0)
HYIPERTENSION Impaired responsiveness of the ventricular sensory receptor in hypertensive patients with left ventricular hypertrophy (0)
[Correlations between polygraphic and hemodynamic parameter changes induced by high concentrated oxygen administration in patients with mitral valvulopathy (author's transl)]. (1980) (0)
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies (2023) (0)
Detection of risk factors in childhood: a new perspective in cardiovascular prevention. (2022) (0)
2009 SIPREC Consensus Document — Executive Summary (2010) (0)
Cost Assessment of the Sick Hospital Syndrome: A Case Study (1996) (0)
Upcoming Challenges for Training in Cardiology (2007) (0)
Search of multiple markers of organ damage for better cardiovascular risk stratification in hypertension: Role of "SHATS" syndrome in the clinical practice. (2018) (0)
[PP.04.18] COMPARISON AMONG DIFFERENT ELECTROCARDIOGRAPHIC CRITERIA FOR LEFT VENTRICULAR HYPERTROPHY: RETROSPECTIVE ANALYSIS OF A LARGE COHORT OF ADULT OUTPATIENTS WITH HYPERTENSION (2017) (0)
Managing hypertension after acute coronary syndrome: missing clinical evidence promote retrospective clues. (2015) (0)
Bempedoic acid: a CLEAR therapeutic option for statin-intolerant patients? (2023) (0)
CS02. Core Symposium: MEASUREMENTS OF OUTCOME IN PSYCHIATRY (2007) (0)
S08. Symposium: NEUROCOGNITIVE IM- PAIRMENT IN SCHIZOPHRENIA: A NEW TARGET FOR TREATMENT (2007) (0)
Selective blockade of AT2 receptors offsets the blood pressure lowering effect of losartan in salt-restricted rats (1998) (0)
P-79: Biological relevance of a proANP molecular variant in human endothelial cells (2003) (0)
Response to letter from Madias regarding our article "Admission heart rate and in-hospital course of patients with Takotsubo syndrome". (2019) (0)
Noradrenaline levels in cerebrospinal fluid of drug-free and pimozide-treated schizophrenic patients. (1983) (0)
Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure (2023) (0)
Combination Therapy for the Clinical Management of Hypertension (2015) (0)
SERUM URIC ACID, INDEPENDENTLY OF ARTERIAL HYPERTENSION, PREDICTS FATAL HEART FAILURE IN A LARGE COHORT OF MEN AND WOMEN. SEARCH FOR A CUT-OFF VALUE (2019) (0)
Hypertension and social determinants in a cohort of migrants acceding an outpatient clinic in Rome (2017) (0)
Targeting blood pressure with a new ARB: focus on azilsartan (2012) (0)
PLATELET MITOCHONDRIA ENHANCE INFLAMMATORY SETTING AND APOPTOSIS IN DIABETIC PATIENTS WITH NSTE ACUTE CORONARY SYNDROME (2019) (0)
A newly designed glucagon-like peptide-1 receptor agonist reduces cardiovascular and renal events in high-risk type 2 diabetes. (2021) (0)
Age-independent benefits of blood pressure lowering: are they applicable to all patients? (2022) (0)
Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR. (2022) (0)
Weekly Journal Scan The cardiovascular benefits of statins outweigh adverse effects in primary prevention: results of a large systematic review and meta-analysis (2021) (0)
High Blood Pressure Cardiovascular Prevention 2011; (2011) (0)
Role of Dickkopf-3 in Blood Pressure Regulation in Mice and Hypertensive Rats. (2023) (0)
Treatment of mild hypertension improves pregnancy outcomes. (2022) (0)
P5661Influence of midwall fractional shortening on incident heart failure and death in asymptomatic subjects at high risk of events. Insights from the DAVID-Berg study (2018) (0)
Exploring the influence of takotsubo syndrome on oncologic patients’ mortality (2022) (0)
Long-term efficacy and safety of renal denervation: another brick for building a hybrid therapy for hypertension? (2022) (0)
Hypertension and the kidney (2007) (0)
COMPREHENSIVE EVALUATION OF EFFICACY OF ANTIHYPERTENSIVE DRUGS IN REDUCING INCIDENCE OF “HOPE” ENDPOINT: A META-ANALYSIS: PP.27.84 (2010) (0)
[OP.6A.06] PREVALENCE AND CLINICAL CHARACTERISTICS OF TRUE MASKED HYPERTENSION COMPARED TO REVERSE AND ISOLATED NOCTURNAL MASKED HYPERTENSION (2017) (0)
1.10 Superiority of Apolipoproteins Compared to Non-HDL Cholesterol in Predicting the Presence of Coronary Disease in Hypertensive Patients with Ischemic Heart Disease (2008) (0)
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention (2023) (0)
1.11 Prevalence of Metabolic Alterations In Hypertensive Patients with Stable vs Unstable Angina (2008) (0)
The UK TAVI trial: an independent, pragmatic study extending the evidence for the treatment of symptomatic severe aortic stenosis. (2022) (0)
Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trials. (2022) (0)
Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides (2011) (0)
814 SLEEP DISORDERS AND DYSBIOSIS: CULPRITS IN CARDIOVASCULAR DISEASES (2022) (0)
Adverse epigenetic remodelling of p66shc gene correlates with persistent endothelial dysfunction and oxidative stress in type 2 diabetics with optimal glycemic control (2013) (0)
Higher hospital readmissions in blacks after acute myocardial infarction: healthcare inequality gaps to fill in secondary prevention. (2023) (0)
Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate. (2022) (0)
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges. (2022) (0)
Deciphering a decision support tool (CoDE-HF) to improve the diagnosis of acute heart failure. (2022) (0)
The enigma of resistant hypertension: from lifestyle changes and pharmacological treatment to renal denervation (2022) (0)
OR-28: AT2-mediated vasorelaxation by angiotensin II in SHR chronically treated with losartan (2002) (0)
The promise of selective aldosterone synthase inhibition for the management of resistant hypertension. (2022) (0)
Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study. (2022) (0)
Diastolic Blood Pressure Levels and Cardiovascular Risk in Elderly Women: The Need for a Personalized Approach. (2022) (0)
Drugs may worsen blood pressure control: focus on the underestimated role of non-steroidal anti-inflammatory drugs. (2022) (0)
Patients Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive (2007) (0)
The New JNC VII and ESH/ISH Hypertension Recommendations (2003) (0)
Reviewers 2018 (2018) (0)
Influenza vaccine for heart failure patients in low- and middle-income countries: another piece in the puzzle. (2023) (0)
A 'Once-and-Done' Approach to the Lifelong Reduction of Elevated Cholesterol. (2021) (0)
755 ATRIAL NATRIURETIC PEPTIDE STIMULATES AUTOPHAGY/MITOPHAGY AND IMPROVES MITOCHONDRIAL DISFUNCTION IN CHRONIC HEART FAILURE (2022) (0)
J011 Abnormalities of renal functional reserve in patients with mild heart failure are corrected by losartan (1998) (0)
Deletion of p66Shc gene restores endothelial function in a mouse model of obesity and insulin resistance. (2011) (0)
Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation. (2022) (0)
[Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine]. (1981) (0)
Long lasting effects of renal denervation: lights and shadows of the SPYRAL HTN-ON MED 3-year follow-up. (2022) (0)
The 'cold case' of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project? (2023) (0)
761 Echocardiographic evaluation in patients recovered from COVID-19 (2021) (0)
T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort. (2020) (0)
SGLT2 inhibitors DELIVER benefits in heart failure independently of ejection fraction and diabetes: end of the line or need for new studies? (2022) (0)
P2597Clinicopathological profiles responsible for advanced heart failure, heart transplantation, left ventricular assist device implantation and death for heart failure in Hypertrophic cardiomyopathy (2018) (0)
[OP.8C.03] IMPROVED ENDOTHELIAL FUNCTION AND E-NOS EXPRESSION AND FUNCTION IN TRANSGLUTAMINASE-2 KNOCK-OUT MICE INFUSED WITH ANGIOTENSIN-II (2016) (0)
Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms (2023) (0)
Worsening of risk factor control in US diabetic patients: a call to action. (2021) (0)
Erratum to: National Survey on Excellence Centers and Reference Centers for Hypertension Diagnosis and Treatment: Geographical Distribution, Medical Facilities and Diagnostic Opportunities (2014) (0)
Reply to the letter "Takotsubo syndrome: Any more covariates of its recurrence?" (2021) (0)
[Preliminary study of the role of arginine vasopressin in arterial hypertension]. (1979) (0)
494 Glycoprotein IIB/IIIA inhibitors may modulate the clinical benefit of radial access as compared to femoral access in primary percutaneous coronary intervention: a meta-regression and a meta-analysis of randomized trials (2021) (0)
P5403Platelet lncRNA and mRNA: unravelling the role of epigenetic modulation in acute coronary syndrome (2019) (0)
The DISCHARGE trial: imaging a new strategy for the clinical management of stable chest pain? (2022) (0)
Obituary: In Memory of Professor Massimo Chiariello (2010) (0)
9.25 Evaluation of Appropriateness of Left Ventricular Mass in a Paediatric Population with Obesity (2008) (0)
Baroreflex Responses in Humans (2005) (0)
In Memoriam: professor Antonio Salvetti (1936-2021). (2021) (0)
In Memory of Professor John H. Laragh (2015) (0)
TRANSFORM-HF closes the loop on diuretic therapy in heart failure. (2023) (0)
SARS-CoV-2 infection markedly increases long-term cardiovascular risk (2022) (0)
ASSOCIATION OF NDUFC2 POLYMORPHIC VARIANTS WITH LEFT VENTRICULAR HYPERTROPHY IN HUMAN HYPERTENSION (2022) (0)
Lipoprotein(a) and the risk of recurrent events in patient with acute myocardial infarction treated by percutaneous coronary intervention. (2022) (0)
Extemporaneous combination therapy with amlodipine/zofenopril in hypertensive patients: a real-world data analysis in Italy. (2023) (0)
P2585Coronary microvascular pathology as the major determinant of severe fibrosis in end-stage hypertrophic cardiomyopathy (HCM) (2018) (0)
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fraction. (2022) (0)
Abstract 533: MAS Receptor Activation Contributes to the Improvement of Vascular Remodeling During Chronic Angiotensin II Type 1 Receptor Blockade in Angiotensin II Type 2 Receptor Knockout Mice. (2012) (0)
Functional analysis of a regulatory mutation of the gene encoding atrial natriuretic peptide (ANP) in stroke-prone SHR (2000) (0)
Altered regulation of ETA receptor subtype by the Japanese style diet in cerebral arterioles of stroke-prone (SP) SHR (1999) (0)
Regulation of 11 beta-hydroxylase cytochrome p450 expression by cholesterol in spontaneously hypertensive rats. (1995) (0)
Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases (2006) (0)
[Coronary effects of left ventricular hypertrophy associated with hypertension]. (1990) (0)
Metabolic Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome (2007) (0)
Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test (2021) (0)
Recommendations for the clinical use of cardiac natriuretic peptides. (2005) (0)
[Renal function in borderline hypertensive close relatives of persons with essential hypertension]. (1981) (0)
Hemodynamic effects of indapamide in chronic treatment of essential hypertension (1984) (0)
Blood pressure regulation mechanisms: The role of the sympathetic nervous and renin angiotensin systems in patients on salt-free diets (1987) (0)
Evaluation of Intermediate Endpoints: Clinical Implications in the Management of Arterial Hypertension (2007) (0)
Another STEP towards tighter control of blood pressure in the elderly (2021) (0)
10.14 Peroxisome Proliferator-Activated Receptors Activator, Rosiglitazone, Improves Vascular Structure and Reduces Lipid Deposition in Atherosclerotic Mthfr Knock-Out Mice (2007) (0)
Natriuretic peptides: Predictive, diagnostic and prognostic implications in cardiovascular diseases with particular regard to acute cardiovascular events (2014) (0)
Combination of ezetimibe and moderate-intensity statin for patients with atherosclerotic cardiovascular disease: a paradigm shift in lipid management landscape. (2022) (0)
The pathophysiology of heart failure. (1991) (0)
[Clinical evaluation of a new antianginal drug: droprenylamine]. (1980) (0)
Abstract 12566: Insulin Resistant Mice Lacking p66Shc Gene are Protected Against Endothelial Dysfunction (2011) (0)
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan? (2022) (0)
Quality of medical records and appropriate hospital stay: two faces of the same coin (2013) (0)
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations (2023) (0)
What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season? (2023) (0)
Streptococcus pneumoniae in hospitalized patients with pneumonia: epidemiology and implications (2020) (0)
Team 2009: Cardiology division,sant-andrea hospital, Rome, Italy: "driven by passion and motivation" to do the best they can for their patients (2009) (0)
[DRG charge and real cost of a radical prostatectomy: preliminary considerations before a study of cost reduction]. (1999) (0)
Correction: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension (2021) (0)
Could the Maternal Ethnicity to be a Determinant in the Healthcare Cost of Assistance at Birth? (2019) (0)
INtegrated Approach (CARMINA) (2013) (0)
Correction: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension (2022) (0)
Microbiological ascertainment in patients with pneumonia: is there room for improvement? (2017) (0)
Can Clinical Governance tools improve the appropriateness in hospital stay (2013) (0)
A gender issue in the diagnostic imaging work-up of stable coronary artery disease? Insights from DISCHARGE. (2022) (0)
Quantification of nursing care and creation of economic indicators: an observational study protocol. (2018) (0)
VP151 Endovenous Iron Deficiency Anemia Treatment In Inflammatory Bowel Disease: Hospital-based Health Technology Assessment (2017) (0)
898 ROLE OF 3D ECHOCARDIOGRAPHY IN AORTIC VALVE ABNORMALITIES: TWO CASES REPORT (2022) (0)
Computed tomography coronary angiography in acute chest pain: an excellent diagnostic tool with poor added value on clinical outcomes (2021) (0)
Protection and delay of aortic complications in the Marfan syndrome: a new indication for angiotensin receptor blockers on top of β blockers. (2022) (0)
7.16 Echocardiographic Evaluation of Left Ventricular Mass in a Population of Paediatric Obese Subjects (2007) (0)
[Prevalence of heart failure in function of age and relative relevance of current clinical trials]. (1999) (0)
Cardiac lipoma of the interventricular septum presenting with chest pain (2023) (0)
[Echocardiographic evaluation of the effects of nadolol on left ventricular performance in hypertensive subjects]. (1982) (0)
[Organization of a health education program for failure]. (1999) (0)
Inflammation and Target Organ Damage in Hypertension With or Without Metabolic Syndrome: 6.14 (2005) (0)
Cosegregation of stroke with altered endothelium-dependent vasorelaxation in the stroke-prone phenotype of spontaneously hypertensive rats. (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Massimo Volpe?

Massimo Volpe is affiliated with the following schools: